KİŞİSEL BİLGİLER

Prof. Dr. Mediha BORAN

Birim: Tıp Fakültesi
Alt Birim: Dahili Tıp Bilimleri-İç Hastalıkları Anabilim Dalı
Personel Tipi: Akademik
Kurumsal E-posta: mediha.boran@bozok.edu.tr
Kişisel E-posta: mediha.boran@bozok.edu.tr
Telefon: 0354 212 70 60 / 3128 / 3128 (Dahili)
Doğum Yeri ve Tarihi: BULGARİSTAN / 1950
Uzmanlık Alanları: İç Hastalıkları ve Nefroloji

EĞİTİM BİLGİLERİ

Derece Üniversite/Okul Bölüm Anabilim Dalı Mezuniyet Yılı
Post DoktoraMarmara Üniversitesi / Tıp FakültesiNefrolojiİç Hastalıkları ABD1993
Post DoktoraAnkara Üniversitesi / Tıp Fakultesiİç Hastalıkları ABDİç Hastalıkları ABD1991

AKADEMİK GÖREVLER

  • 1991 - 1991 : Ankara Üniversitesi, İç Hastalıkları ABD,İç Hastalıkları Uzmanı
  • 1993 - 1993 : Marmara Üniversitesi,İç Hastalıkları ABD, Nefroloji BD, Nefroloji Uzmanı
  • 2000 - 2000 : İstanbul Üniversitesi Çapa Tıp Fakültesi,İç Hastalıkları ABD, Doçent
  • 1989 - 2015 : Türkiye Yüksek İhtisas Eğitim ve Araştırma Hastanesi,Nefroloji

YAYINLAR

MAKALE

ULUSLARARASI
SCI, SSCI, AHCI Kapsamında Makale
  • A1.Boran M, Tola M, Boran E, Boran M. Doppler ultrasound findings in kidney transplant recipients with and without of new onset diabetes mellitus beyond 5 years after transplantation. Int J Clin Exp Med. 2015 Sep 15;8(9):16709-16713.
  • A2. M. Boran, T.Yıldırım, E.Boran, M.Boran and H. Kılıc, Late-onset BKviruria in Renal Transplant Recipient; Transplantation Proceedings, 47 :1786-1789,2015. doi:10.1016 /j. Transproceed .2015.06.028
  • A3. M. Boran, M. Tola, M. Boran, E. Boran, F. Gönenç, Determining Renal Resistive and Pulsatility Indexes Long-Term After Kidney Transplantation in Kidney Transplant Recipients on Cyclosporine A-, Tacrolimus-, or Sirolimus-Based Regimens; Transplantation Proceedings, 46(5):1324-1327,2014,doi:10.1016/j.transproceed. 2014 .09.056, PMID 24935296
  • A4. M. Boran, M.Boran, E.Boran, HLA-Identıcal Sıblıng Renal Transplantatıon: Influence Of Donor And Recıpıent Gender Mısmatch On The Long -Term Outcomes. Transplantation Proceedings, 46(10):3423-3425,2014 DOI:10.1016/ j.transproceed.2014.06.076.PMID 25498065
  • A5. I.Bahar, Akgul A, Demirbag AE, Altinay L, Thompson LO, Boran M, Ozatik MA, Birincioglu L. Open Heart Surgery in Patients with End Stage Renal Failure: Fifteen Year Experience. Journal of Cardiac Surgery vol 24 (1) pp 24 -29, 2009 .
  • A6. Tosun O, Davutluoglu B, Arda K, Boran M, Yarangumeli A, Kurt A, Ozkan D. Determination of the effect of a single hemodialysis session on retrobulbar blood hemodynamics by color Doppler ultrasonography Acta Radiologica, 2007 vol 48(7):763-7. doi:10.1080/02841850701348713
  • A7. Bahar I, Akgul A, Ozatik MA, Vural KM, Demirbag AE, Boran M, Tasdemir O.Acute renal failure following open heart surgery: risk factors and prognosis.Perfusion, 2005; 20 (6) :317- 22. (ISSN: 0267–6591)
  • A8. Ozdemir O, Boran M, Gökçe V, Uzun Y, Koçak B, Korkmaz S. A case with severe rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy--a case report. Angiology, 2000 ;51(8):695-697(PMİD:10959522)
  • .A9. Yetkin E, Ileri M, Tandoğan I, Boran M, Yanik A,Hisar I, Kutlu M, Cehreli S, Korkmaz S, Göksel S. Increased QT interval dispersion after hemodialysis: role of peridialytic electrolyte gradients. Angiology, 2000; vol 51 (6) : 499-504. doi: 10.1177 / 000331970005100607
  • A10. Boran M, Gönenç F, Cetin S; Correlation between salt-depleted diet and chronic ciclosporin-induced nephropathy in living-related donor renal transplant recipients.; Nephron. 1999;83(3):280-281.pmed 10529640
  • A11. Boran M, Gönen F, Cetin S.Losartan in renal allograft recipients receiving cyclosporine A.Nephron. 1999 Sep; 83(1): 93-94; pmid 106-461044
  • A12. Boran M, Bozdayi M, Cetin S Arachidonic acid metabolites as biocompatibility parameters for cellulosic membranes. Nephrology Dialysis Transplantation, 1999; 14(7):1804-5 ; pmid 10435906
  • A13. Boran M, Cetin S.Helicobacter pylori and Giardia lamblia infections in hemodialysis patients. Nephrology Dialysis Transplantation. 1999;14(7):1803-1804; pmid10435905
  • A14. Boran M, Çetin S. Influence of aminosteril on serum parathyroid hormone levels in hemodialysis patients. Nephron. 1999;82(1):75-76.pmid10224489
  • A15. Boran M, Çetin S. The role of alpha-glutathione S-transferase in the monitoring of hemodialysis patients with hepatitis C virus infection undergoing high-dose interferon-alpha-2b therapy.,Nephron. 1999; 82( 1):22-26. pmid10224480
  • A16. Boran M, Küçükaksu C, Balk M, Cetin S Red cell lipid peroxidation and antioxidant system in haemodialysed patients: influence of recombinant human erythropoietin (r-HuEPO) treatment. International Urology and Nephrology, 1998;30(4):507-12.pmid 9821056
  • A17. Boran M, Cetin S. Effectiveness of intravenous and subcutaneous calcitriol in the treatment of secondary hyperparathyroidism. Nephron. 1998 Sep;80(1):119-20.
  • A18. Boran M, Cetin S. Plasma alpha-glutathione S-transferase (alpha-GST) as a marker of liver damage in hemodialysis patients..Nephrology Dialysis Transplantation, 1998 May; 13(5):1323-1324. doi:10.1159/000045363
  • A19. Boran M, Doruk E, Gönenç F, Cetin S. 1.25(OH)2 cholecalciferol pulse therapy and the effects of different dialysis membranes on serum PTH levels of haemodialysis patients., International Urology and Nephrology, 1997 ; 29 (2): 251-258.
  • A20. Boran M, Güneş Z, Doruk F, Gönenç F, Cetin S. Improvement in cyclosporine A associated gingival hyperplasia with azithromycin therapy., Transplantation Proceedings,1996 ;28 (4): 2316. (PMİD:8769234)
  • A21. Boran M, Dalva I, Gönenç F, Cetin S. Response to recombinant human erythropoietin (r-Hu EPO) and L-carnitine combination in patients with anemia of end-stage renal disease..Nephron. 1996;73(2):314-315 doi:10.1159/000189060
  • A22. Boran M, Göl MK, Sener E, Taşdemir O, Cetin S, Bayazit K. Coronary artery bypass grafting in chronic renal dialysis patients: intensive perioperative dialysis and extensive usage of arterial grafts., European Journal Cardiothoracic Surgery. 1995;9(12):719.
  • A23. Boran M, Göl MK, Şener E, Taşdemir O, Bayazit K. Open Heart Surgery in Patients with Chronic Renal Failure; Asian Cardiovascular and Thoracic Annals,1995;vol 3 (4):112-116
  • A24. T Akpolat, N Arık, M Günaydın, C Utaş, K Dilek, Ş Çağlar, F Candan, G Süleymanlar, S Paydaş, S Şen, S Kürşat, M Yeksan, E Akoglu, M Boran, M Arınsoy, S Bozfakıoğlu, T Çamsarı, Z Tombul, A Vural, R Ataman. Prevalence of anti-HCV among haemodialysis patients in Turkey: a multicentre study; Nephrology Dialysis Transplantation vol 10(4):479-480, 1995 .ISSN1460-2385
  • A25. Boran M, Göl MK, Kalaycıoğlu S, Davla I, Taşdemir O. Çetin S, Bayazit K.Pump assisted continuous veno-venous hemodiafiltration in the treatment of acute renal failure-Türkiye Klinikleri, Journal of Medical Sciences, 1995 ;vol13(1): 31-33
  • A26. Boran M ,Çağla A ,Çetin S, The Effect Of Different Membranes On Sleep Rhythm İn Hemodialysis Patients , Türkiye Klinikleri ,Journal of Medical Sciences, 1995 ;13(5):198-200.
  • A27. Boran M, Dalva I, Yazicioğlu A, Cetin S Subcutaneous versus intravenous recombinant human erythropoietin administration in hemodialysis patients.Nephron. 1993;63(1):113-4. , pmid 8446239
  • A28. Boran M, Dalva I, Yazicioğlu A, Akbay E, Cetin S Correction of anaemia in haemodialysis patients with recombinant human erythropoietin. International Urology and Nephrology. 1993;25(2):197-203.
Diğer Hakemli Dergilerde Makale
  • A29. BORAN M. Boran E, Gok Oğuz E , Boran M. Bk Virus Prevalence İn The Plasma Of Chronıc Kıdney Disease Patients Awaiting Renal Transplantatıon. British Journal Of Medicine & Medical Research 2016; 15(3): 1-5. Issn: 2231-0614, Doı: 10.9734/Bjmmr/2016/2545
ULUSAL
Hakemli Dergilerde Makale
  • D1. Arda K, Boran M, Sığırcı A, Yavuz Y. Renal Allograft Disfonksiyonlarının Belirlenmesinde Kullanılan Kan Kreatinin Düzeyleri İle Rezistans İndeksi İle İlişkisi; Turgut Özal Tıp Merkezi Dergisi 1999; Vol 6 (2) pp126-129
  • D2. Boran M. Hiperürisemide Lozartan Tedavisi. British Medical Journal Türkiye Dergisi 1998;3 (3) Pp 6-7
  • D3. Erden A Boran M. Alimoğlu E, Ateşçi M, Ölçer T, Çetin S. Hemodializ Hastalarında Karpal Tunel ve Palmar Radiokarpal Ligament Kalınlığının Hemodializ Süresi İle Korelasyonu (Ultrasonografik Değerlendirilme) Türk Nefroloji Diyaliz Ve Transplantasyon Dergisi, Journal of The Turkish Nephrology Association,1997; 6(3-4) pp159-163
  • D4. M Boran, S Çetin. Asitli Hemodializ Hastalarında Tüberküloz Peritonit Unutulmamalı Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, Journal of The Turkish Nephrology Association,1997; Vol 3(4) Pp 171-172
  • D5. Erden A, Boran M, Çalıkoğlu Ü,Tola M, Saraçyakupoğlu D, Ölçer T, Cumhur T. Thyroid Lesions In Patients With Chronic Renal Failure Undergoing Regular Hemodialysis: Assessment With Ultrasonography. Journal Of Ankara Medical School,1996;18 (4):203-205.
  • D6. Boran M, Doruk E, Gönenç F, Çetin S. Hemodializ Hastalarında Yüksek Doz 1.25 (Oh) 2 Kolekalsiferol Uygulaması Ve Kullanılan Değişik Membranların Serum Paratiroid Hormon(Pth ) Düzeyi Üzerine Etkisi Türk Nefroloji Dializ Ve Transplantasyon Dergisi, Official Journal Of The Turkish Nephrology Association, 1995; Vol 2 pp 91-96
  • D7. Korkmaz Ş, Sözütek Y, Boran M, Erdoğan A, Oğuzhan A, Özdemir K. Kronik Böbrek Yetmezliği Olan Hastalarda Koroner Anjiografi Ve Perkutan Transluminal Koroner Anjioplasti, Medical Network Kardioloji, 1995; 2 (1) pp 22-25
  • D8. Boran M, Kural T, Korkmaz Ş, Çetin S, Göksel S. Hemodializ Hastalarında Transplant Öncesi ve Sonrası Sol Ventrikül Fonksiyonlarının Değerlendirilmesi Türk Nefroloji Dializ ve Transplantasyon Dergisi, Official Journal Of The Turkish Nephrology Association, 1995; 2:115-118
  • D9. Boran M, Doruk E, Özcan M, Çetin S. Hemodializ Hastalarında R-Hu Epo Tedavisinin Lipid Profili Üzerine Etkisi, Nefroloji Ve Hipertansiyon, 1994; 2(3):37-40
  • D10. Boran M, Doruk E, Özcan M, Çetin S. High-Flux Hemodializ Uygulanan Hastalarda Lipid Profili, Nefroloji Ve Hipertansiyon,1994; 2 (3) : 41- 46
  • D11. Boran M, Akbay E, Sarıtaş Ü, Doruk E, Gönenç F, Çetin S. Hemodializ Ve Renal Transplantasyonlu Hastalarda Hepatit C Virüs Antikor Prevalansı Ve Karaciğer Enzmleri İle Korelasyonu; Nefroloji Ve Hipertansiyon, 1993 1(1):31-35
  • D12. Şener E, Yapıcı F, Göl MK, Boran M, Karagöz H, Taşdemir O, Bayazit K. Kronik Böbrek Yetmezlikli Hastalarda Açık Kalp Cerrahisi, Türkiye Klinikleri, Journal Of Cardiology, 1993;Vol 6 (3): 247-251
  • D13. Sarıtaş, Ü, M. Boran, Dağlı Ü, Yılmaz U, Başar M, Şaşmaz N. Hemodializ Hastalarında Hepatitis C Virus Antikorları Prevalansı. Gastroenteroloji Vol 4: 594 - 597, 1993.
  • D14. Boran M, Karahan M, Dalva I, Akbay E, Kılıç H, Çetin S. Hemodializ Hastalarında Stafilokokus Aureus Nazal Taşıcılığı Ve Tedavisi; Nefroloji Ve Hipertansiyon, 1992; 1(1):17-20
  • D15. Boran M, Bozdağı M, Saydam G, Dalva I, Dalva K, Çetin S. Hemodializ Süresince, Dializ Membranlarının Trombosit Fonksiyonlarına Ve Kompleman Aktivasyonuna Etkiler; Turkiye Klinikleri, Journal Of Medical Research, 1992; 10(4): 34-37
  • D16.Boran M, Dalva I, Yazıcıoğlu A, Çetin S. Hemodializ Hastalarında Serun B2 Mikroglobulin “Kuprofan” Ve “Polisulfon-F60” Membranların Karşılaştırması. Turkish Journal Of Medical Research Vol 10(4): 217-220,1992

BİLDİRİ

ULUSLARARASI
  • 1.Boran M, Tola M, Boran M, Boran E; Renal Resistance Indices After Kidney Transplantation; American Journal of Transplantation,2014 vol 14, issue S3, pp 571, (doi/10.1111/1jt.v14.S 3/issuetoc)
  • 2. Boran M, Boran M, Boran E,Kılıç H,Oğuz E G,Yurdakul D,Parlak P.Polyoma Viral Replication on Plasma in End-stage Rnenal Disease Patients Waiting for Renal Transplantation. Journal American Society of Nephrology, Abstract supplement, vol 25, November 2014.
  • 3. Boran M, Boran M, Boran E,Gönenç F. Lower Incıdence Of Post- Transplant Dıabetes Mellıtus After Kıdney Transplantatıon Wıth Reduced Tacrolımus Levels And Angıotensın Receptor Blocker. Journal American Society of Nephrology, Abstract supplement, vol 24, November 2013.
  • 4. M Boran, E Boran, M Boran: HLA Identical Living Donor Kidney Transplantation; Transplant International,2013 vol 26, supp 2, pp235.
  • 5. Boran M, Gönenç F, Çetin S. Hypomagnesemia in living-related kidney transplantation Nephrology Dialysis Transplantation,1998, vol 13(6) pp 262
  • 6. Boran M, Gönenç F, Çetin S. Effect of concordance and discrepancy in gender among living donors and recipients on the kidney transplantation outcome. Nephrology Dialysis Transplantation,1998, vol 13(6) pp262
  • 7. Boran M, Gönenç F, Çetin S.Short-term effect of angiotensin-converting enzyme inhibitor (ACEI) and angiotensin II receptor antagonist (ARA) on erythrocytosis and hyperuricaemia in living-related donor (LRD) kidney transplantation. Nephrology Dialysis Transplantation,1998, vol 13(6) pp262
  • 8. Boran M, Çetin S The role of alpha-glutathione S-transferase in the monitoring of hemodialysis patients with hepatitis C virus infection undergoing high-dose interferon-alpha-2b therapy. Nephrology Dialysis Transplantation,1998, vol 13 (6) pp152.
  • 9. Boran M, Çetin S.The effect of low dose subcutaneus calcitriol treatment on secondary hyperparathyroidism Nephrology Dialysis Transplantation,1998, vol 13(6) pp152.
  • 10. Boran M, Cetin S. Plasma alpha-glutathione S-transferase (alpha-GST) as a marker of liver damage in hemodialysis patients. Nephrology Dialysis Transplantation, 1998;13(6) pp152
  • 11. Boran M, Bozdayi M, Cetin S Arachidonic acid metabolites as biocompatibility parameters for cellulosic membranes. Nephrology Dialysis Transplantation, 1998; 13(6) pp153
  • 12. Boran M, Doruk E, Köselerli R, Çetin S. The effects of r-HU EPO treatment on the lipid profile of hemodialysis patients, Nephrology Dialysis Transplantation, 1995; vol 10(6) pp 1045.
  • 13. Boran M, Göl MK, Şener E, Taşdemir O,Bayazit K. Open Heart Surgery in Patients with Chronic Renal Failure; Nephrology Dialysis Transplantation, 1994; vol 9 (7) pp 976
  • 14. M Boran, I Dalva, S Sargın, E Akbay, A Erol, S Göksel, S Çetin. Effect of human erythropoietin on ventricular function in hemodialysis patients Nephrology Dialysis Transplantation, 1994; vol 9 (1) pp 107.
  • 15. M Boran, K Dalva, M Beksaç, I Dalva, Ş Yıldız, S Çetin. Short term effects of different hemodialysis membranes on sİL-2R, sCD23 and beta- 2 microglobulin levels. Nephrology Dialysis Transplantation, 1994; vol 9 (1) pp 106.
  • Boran M, Tola M, Boran M, Boran E, Gönenç F. Renal Resistance Indıces After Kıdney Transplantatıon. World Transplant Congress, July 26-31, 2014, San Francısco, California
  • Boran M, Boran E, Boran M. HLA Identıcal Lıvıng Donor Kıdney Transplantatıon: Long- Term Outcomes. 16.Congress Of The European Society For Organ Transplantation (Esot), 30 September - 03 October, 2013, Vıenna, Austrıa
  • Boran M, Çetin S. Influence of Aminosteril on Serum Parathyroid Hormone levels in Hemodialysis Patients. XV th International Congress of Nephrology, XIth Latin American Congress of Nephrology, May 2-6.1999,Buenos Aires, Argentina
  • Boran M, GönençF, Çetin S. Losartan in renal allograft recipients receiving cyclosporin A. International forum on angiotensin II receptor antagonism, International Society of hypertension, The American Society of Hypertension, European Society of Hypertension Janury 27-30,1999,Monte-Carlo.
  • Boran M, Gönenç F, Çetin S.I mproved long-term kidney graft survival achieved by nephroprotective therapy in patients with biopsy proven chronic renal allograft rejection (CRAR) XXXV Congress of the European Renal Association, European Dialysis and Transplant Association, September 5-8, 1999, Madrid, Spain
  • Yıdız S, Boran M, Güneş Z, Koçak B, Gönenç F, Çetin S. Changes in pituitary-testicular function following renal transplantation. XXXV Congress of the European Renal Association, European Dialysis and Transplant Association, September 5-8, 1999, Madrid, Spain
  • Boran M,Çetin S. Effects of the Combination of Losartan and Verapamil+Trandolapril on Proteinuria and Renal Function in Nephrotic Syndrome. XXXV Congress of the European Renal Association, European Dialysis and Transplant Association, September 5-8, 1999, Madrid, Spain
  • Boran M, Gönenç F, Çetin S. Hypomagnesemia in living-related kidney transplantation. XXXV Congress of the European Renal Association, European Dialysis and Transplant Association, June 6-9, 1998, Rimini, Italy
  • Boran M, Gönenç F, Çetin S. Effect of concordance and discrepancy in gender among living donors and recipients on the kidney transplantation outcome. XXXV Congress of the European Renal Association, European Dialysis and Transplant Association, June 6-9, 1998, Rimini, Italy
  • Boran M, Gönenç F, Çetin S.Short-term effect of angiotensin-converting enzyme inhibitor (ACEI) and angiotensin II receptor antagonist (ARA) on erythrocytosis and hyperuricaemia in living-related donor (LRD) kidney transplantation. XXXV Congress of the European Renal Association, European Dialysis and Transplant Association, June 6-9, 1998, Rimini, Italy
  • Boran M, Çetin S. Plasma alpha-glutathione S-transferase (alpha-GST) as a marker of liver damage in hemodialysis patients. XXXV Congress of the European Renal Association, European Dialysis and Transplant Association, June 6-9, 1998, Rimini, Italy
  • Boran M, Çetin S The role of alpha-glutathione S-transferase in the monitoring of hemodialysis patients with hepatitis C virus infection undergoing high-dose interferon-alpha-2b therapy. XXXV Congress of the European Renal Association, European Dialysis and Transplant Association, June 6-9, 1998, Rimini, Italy
  • Boran M, Çetin S.The effect of low dose subcutaneus calcitriol treatment on secondary hyperparathyroidism. XXXV Congress of the European Renal Association, European Dialysis and Transplant Association, June 6-9, 1998, Rimini, Italy
  • Boran M, Çetin S. Arachidonic acid metabolites as biocompatibility parameters for cellulosic membranes. XXXV Congress of the European Renal Association, European Dialysis and Transplant Association, June 6-9, 1998, Rimini, Italy
  • Boran M, Köselerli R.The effect of Carnitene on the lipid profile of hemodialysis patients. XIII th International Congress of Nephrology, July 2-6, 1995, Madrid, Spain
  • Boran M, Çağla A, Köselerli R,Çetin S.The effect of different dialysis membranes on the sleep rhythm. XIII th International Congress of Nephrology, July 2-6, 1995, Madrid, Spain.
  • Boran M, Özdemir N, Köselerli R, Gönenç F, Çetin S. 1.25(OH)2 cholecalciferol pulse therapy and the effects of different dialysis membranes on serum PTH levels of hemodialysis patients. XIII th International Congress of Nephrology, July 2-6, 1995, Madrid, Spain.
  • Boran M, Köselerli R, Gönenç F, Çetin S. The effects of Carnitene in renal transplant patients with hiperlipidemia. XIII th International Congress of Nephrology, July 2-6, 1995, Madrid, Spain
  • Boran M, Doruk E, Köselerli R, Çetin S. The effects of r-HU EPO treatment on the lipid profile of hemodialysis patients, XXXII Nd Congress Of The European Renal Association, European Dialysis And Transplant Association, June 11-14, 1995, Athens, Greece
  • Boran M, Dalva K, Beksaç M,Dalva I, Çetin S.Short-term effects of different hemodialysis membranes on serum soluble interleukin 2 receptor, soluble CD23 and beta 2 microglobulin levels. The First International Congress on Dialysis in Developing Countries, 2-5 november, 1994, Singapure.
  • Boran M, Sarıtaş Ü, Gönenç F, Çetin S.The prevalance of C virus antibodies in hemodialysis unit. The First International Congress on Dialysis in Developing Countries, 2-5 november, 1994, Singapure.
  • Boran M, Dalva I, Küçükaksu C, Balk M, Çetin S.Red cell lipid peroxidation and antioxidant system in hemodialysed patients: influence of r-Hu EPO treatment. The First International Congress on Dialysis in Developing Countries, 2-5 november, 1994, Singapure.
  • Boran M, Küçükaksu C, Balk M, Çetin S.Comparison of red cell lipid peroxidation and antıoxidant system in CRF patients treated with r-Hu EPO using different membranes. The First International Congress on Dialysis in Developing Countries, 2-5 november, 1994, Singapure.
  • Boran M, Şener E, Taşdemir O, Beyazid K.Open Heart Surgery in patients on Chronic Renal Failure. XXXI St Congress Of The European Renal Association, European Dialysis And Transplant Association, July 3-6,1994, Vienna, Austria
ULUSAL
  • . Boran M, Gönenç F, Yıldız Ş, Ölçucuoğlu E, Ekmekçıoğlu O Akıcı S, Böbrek Naklinde Farklı İki İmmunuspresif Protokolün Etkinliğinin Karşılaştırması. Transplantasyon Kongresi (TONKKD VI. Kongresi), 15-18.Ekim 2008, Erzurum
  • E2 Yıldız Ş, Akıncı S, Boran M, Gönenç F. Renal Transplantasyonda Klinik Everolomus Deneyimlerimiz. Transplantasyon Kongresi (TONKKD VI. Kongresi), 15-18. Ekim 2008 Erzurum
  • E3. Balcı M, Gariboğluş, Özatik M A, Boran M, Küçükaksu S, Gönenç F. CD4+CD25+Regulatuar T Hücreleri Böbrek Ve Kalp Transplantların Takibinde İmmun Tolerans İçin Bir Gösterge Olabilir Mi. Transplantasyon Kongresi (TONKKD IV.Kongresi), 15-19 Eylül 2004 Kapadokya
  • E4. Koçak B, Güneş Z, Sönmezer Ö, Boran M, Balcı M, Gönemç F. Renal Transplantasyon Hastalarında C2 Monitorizasyonu. Transplantasyon Kongresi (ONKKD III. Kongresi), 17-20 Ekim 2002, Adana
  • E5. Balcı M, Boran M, Gönenç F. Transplantasyon Öncesi Eliza Yöntemi İle Panel Reaktif Antikor (Pra) Tarama Ve Klinik Önemi. Transplantasyon Kongresi (ONKKD III. Kongresi), 17-20 Ekim 2002, Adana
  • E6. Boran M, Gönenç F, Çetin S.Kronik Renal Allograft Rejeksiyonunda Diltiazem Ve Losartan Kombinasyonun Nefroprotektif Etkinliği. I.Ulusal Hipertansiyon Ve Böbrek Hastalıkları Kongresi, 26-30 Mayıs 1999, Antalya
  • E7. BORAN M, Çetin S. Losartan ve Verapamil+Trandolapril Kombinasyonun Primer Glomerulonefritlerde Proteinuri, Hipertansiyon ve Böbrek Fonksiyonu Üzerine etkinliği. I.Ulusal Hipertansiyon Ve Böbrek Hastalıkları Kongresi, 26-30 Mayıs 1999, Antalya
  • E8..Yıldız Ş, Boran M, Güneş Z, Koçak B, Gönenç F, Çetin S. Renal transplantasyon sonrası pitüiter testikuler fonksiyonlardaki değişmeler. XVI. Ulusal Nefroloji, Hipertansiyon, Dializ ve Transplantasyon kongresi, 14-18 Kasım, 1999, İzmir
  • E9.Balcı M, Elhan A, Boran M, Batur N, Gönenç F.Türkiyede HLA polimorfizmi: 247 ailede bir haplotip çalışması. XVI. Ulusal Nefroloji, Hipertansiyon, Dializ ve Transplantasyon kongresi, 14-18 Kasım, 1999, İzmir
  • E10. Balcı M, Elhan A, Boran M, Garipoğlu Ş, Gönenç F Türk toplumunda HLA antijen ve allel frekansları. XVI. Ulusal Nefroloji, Hipertansiyon, Dializ ve Transplantasyon kongresi, 14-18 kasım, 1999, İzmir
  • E11. Boran M, Gönenç F, Çetin S. Enapril ve Losartan’ın post-transplant eritrositosis ve hiperurisemide etkileri. Transplantasyon Kongresi (ONKKD I.Kongresi, 11-15 Kasım 1998, Antalya
  • E12. Boran M, Gönenç F, Çetin S.Canlı Donor Böbrek Nakillerinde Siklosporin A Tedavisine bağlı hipomagnezeminin prevalansı. Transplantasyon Kongresi (ONKKD I.Kongresi, 11-15 Kasım 1998, Antalya
  • E13. Boran M, Çetin S. Hemodializ hastalarında helikobakter pilory enfeksiyonu ve giardia lamblia parasitozisi. XV. Ulusal Nefroloji, Hipertansiyon, Dializ ve Transplantasyon kongresi ve Uluslararası Yaz Okulu, 4-9 Ekim, 1998, İzmir
  • E14. Boran M, Çetin S. Hemodializ hastalarında esansiyal aminoasit tedavisinin serum paratiroid hormon düzeyi üzerine uzun süreli etkisi. XV. Ulusal Nefroloji, Hipertansiyon, Dializ ve Transplantasyon kongresi ve Uluslararası Yaz Okulu, 4-9 Ekim, 1998, İzmir
  • E15.Arda K, Boran M, Çelik N, Ölçer T, Cumhur T. Renal Allograft Disfonksiyonlarının belirlenmesinde kullanılan değişik kan kreatinin düzeyleri ile resistans indeksi ilişkisi. 6. Ulusal Ultrasonografi Kongresi, 5-9 Ekim 1997,Kuşadası
  • E16.Arda K, Boran M, Çelik N, Ölçer T, Cumhur T. Normal ve disfonksiyone renal transplant hasta grupları arasında Doppler USG bulgularının karşılaştırılması. 6. Ulusal Ultrasonografi Kongresi, 5-9 Ekim 1997,Kuşadası
  • E17. Erdem A, Boran M, Alimoğlu E, Ateşçi M, Ölçer T, Çetin S. Hemodializ hastalarında karpal tunel sendromunun ultrasonografi ile değerlendirilmesi. XIV Ulusal Nefroloji, Hipertansiyon, Dializ ve Transplantasyon kongresi, 10-14 Kasım, 1997, Antalya
  • E18. Boran M, Çetin S. Sekonder hiperparatiroidizmin tedavisinde subkutan calsitriol’un kullanışlığı ve etkinliği. XIV Ulusal Nefroloji, Hipertansiyon, Dializ ve Transplantasyon kongresi, 10-14 Kasım, 1997, Antalya
  • E19. Güneş Z, Boran M, Doruk E, Dalva I, Gönenç F, Çetin S.Sandimmun’dan Neoral’e 1:1 oranındaki dönüşümün böbrek fonksiyonlarına etkisi: Erken dönem sonuçları. Türkiye Organ Nakli Derneği, Birinci Bilimsel Kongresi, Transplantasyonda 20 yıl, 2-7 kasım 1995,Ankara
  • E20. Boran M, Güneş Z, Davla I, Doruk E, Gönenç F, Çetin S. Cyclosporin A bağlı gingival hiperplazinin Azithromycin ile tedavisi. Türkiye Organ Nakli Derneği, Birinci Bilimsel Kongresi, Transplantasyonda 20 yıl, 2-7 Kasım 1995,Ankara
  • E21. Boran M, Davla I, Gönenç F, Çetin S. Hemodializ hastalarında r-Hu EPO ve L-Carnitine tedavisinin anemi üzerine etkisi. XII. Ulusal Nefroloji, Hipertansiyon, Dializ ve Transplantasyon kongresi, 3-7 Ekim1995, Abant.
  • E22. Boran M, Davla I, Gönenç F, Çetin S. Subkutan düşük doz Calsitriol tedavisinin sekonder hiperparatiroidizm üzerine etkisi. XII. Ulusal Nefroloji, Hipertansiyon, Dializ ve Transplantasyon kongresi, 3-7 Ekim1995, Abant.
  • E23. Boran M, Özdemir C, Gönenç F, Çetin S. Renal Transplantasyon sonrası gelişen hiperlipidemide Carnitene tedavisi. Türkiye Organ Nakli Derneği, İkinci Bilimsel Kongresi, 8- 9 Kasım 1994, Ankara
  • E24. Davla I, Bayrak E, Gönenç F, Boran M, Saydam G, Çetin S. Renal Transplant ve Hemodializ hastalarında lipoprotein (a) düzeyi. Türkiye Organ Nakli Derneği, İkinci Bilimsel Kongresi, 8- 9 Kasım 1994, Ankara
  • E25. Boran M, Doruk E,Özcan M, Çetin S. Hemodializ hastalarında r-Hu EPO tedavisinin lipid profili üzerine etkisi. XI. Ulusal Böbrek Hastalıkları, Dializ ve Transplantasyon kongresi,11-14 Ekim 1994, Samsun
  • E26.Boran M, Çağla A, Çetin S. Hemodializ hastalarında değişik membranların uyku ritmi üzerine etkisi. XI. Ulusal Böbrek Hastalıkları, Dializ ve Transplantasyon kongresi,11-14 Ekim 1994, Samsun
  • E27. Boran M, Doruk E,Özcan M, Çetin S.High-flux hemodializ uygulanan hastalarda lipid profili. XI. Ulusal Böbrek Hastalıkları, Dializ ve Transplantasyon kongresi,11-14 Ekim 1994, Samsun
  • E28. Boran M, Doruk E, Çağlı A, Gönenç F, Çetin S. Hemodializ hastalarında kullanılan değişik membranların serum PTH düzeyi üzerine etkisi. XI. Ulusal Böbrek Hastalıkları, Dializ ve Transplantasyon kongresi,11-14 Ekim 1994, Samsun
  • E29. Boran M, Kural T, Davla I,Çetin S. r-Hu EPO uygulanan hemodializ hastalarında transplant öncesi ve sonrası sol ventrikül fonksiyonlarının değerlendirilmesi. XI. Ulusal Böbrek Hastalıkları, Dializ ve Transplantasyon kongresi,11-14 Ekim 1994, Samsun
  • E30.Dalva K, Davla I, Batur N, Boran M, Çetin S, Beksaç M. Renal transplantasyon yapılan hastalarda Sicam Düzeyleri. XI. Ulusal Böbrek Hastalıkları, Dializ ve Transplantasyon kongresi,11-14 Ekim 1994, Samsun
  • E31.Boran M, Doruk E, Özdemir C, Özcan M, Çetin S. Hemodializ hastalarında yüksek doz 1.25(OH)2 kolekalsiferol uygulaması. XI. Ulusal Böbrek Hastalıkları, Dializ ve Transplantasyon kongresi,11-14 Ekim 1994, Samsun
  • E32. Boran M, Göl K, Kalaycıoğlu S, Davla I, Taşdemir O,Çetin S. Akut böbrek yetmezliğinde pompa destekli sürekli veno-venöz hemodiafiltrasyon uygulanması. XI. Ulusal Böbrek Hastalıkları, Dializ ve Transplantasyon kongresi,11-14 Ekim 1994, Samsun
  • E33. T Akpolat,N Arık,M Günaydın,C Utaş, K Dilek, Ş Çağlar, F Candan, G Süleymanlar, S Paydaş, S Şen, S Kürşat, M Yeksan, E Akoglu, M Boran, M Arınsoy, S Bozfakıoğlu, T Çamsarı, Z Tombul, A Vural, R Ataman.Türkiye’de hemodializ hastalarında HCV sonucu. XI. Ulusal Böbrek Hastalıkları, Dializ ve Transplantasyon kongresi,11-14 Ekim 1994, Samsun
  • E34. Korkmaz Ş, Sözütek Y, Boran M, Erdoğan A, Oğuzhan A. Kronik böbrek yetmezliği hastalarında koroner anjiyografi ve perkutan transluminal koroner anjioplasti. II. Ulusal İnvaziv Kardioloji Kongresi, 22-24 haziran 1994, İzmir.
  • E35. Dalva K, Boran M, Akbay E, Davla I,Gönenç F, Çetin S. Hemodializ hastalarında gecikmiş tip hipersensivitenin multitest CMİ ile değerlendirilmesi. Türkiye Organ Nakli Derneği Birinci Bilimsel Kongresi ve Dünya Yapay Organ İmmunoloji ve Organ Nakli Derneği İkinci Uluslar arası Toplantısı, 20-23 ekim 1993, Ankara
  • E36. Akbay E, Sarıtaş Ü, Akman Y, Boran M,Davla I,Gönenç F. Renal transplantasyon yapılmış hastalarda hepatitis C virüsü antikor prevalansı. X. Ulusal Böbrek Hastalıkları, Dializ ve Transplantasyon kongresi 19-22 Ekim 1993, Bursa.
  • E37. Boran M, Sarıtaş Ü, Gönenç F, Çetin S.Hemodializ ünitesinde Hepatit C virüsü antikor prevalansı. X. Ulusal Böbrek Hastalıkları, Dializ ve Transplantasyon kongresi 19-22 Ekim 1993, Bursa.
  • E38. Boran M, Küçükaksu C, Davla I, Çetin S. r-Hu EPO uygulanan ve uygulanmayan hemodializ hastalarında lipid peroksidasyon ve antioksidan sistem göstergelerinin karşılaştırılması. X. Ulusal Böbrek Hastalıkları, Dializ ve Transplantasyon kongresi 19-22 ekim 1993, Bursa.
  • E39. Şener E, Yapıcı F, Boran M, Taşdemir O, Bayazit K. Kronik böbrek yetmezlikli hastalarda açık kalp cerrahisi. VIII. Ulusal Kardioloji Kongresi, 27 Eylül - 1ekim 1992, İstanbul
  • E40. Boran M, Dalva K, Beksaç M, Davla I,Yıldız Ş, Çetin S. Hemodializ membranlarının Sil-2R,sCD23 ve beta 2 mg düzeylerine etkileri. IX. Ulusal Böbrek Hastalıkları, Diyaliz ve Transplantasyon kongresi, 01-04 Ekim 1992, Ürgüp.
  • E41.Boran M, Sargın S, Akbay E, Erol A, Göksel S, Çetin S. Hemodiyaliz hastalarına uygulanan r-Hu EPO ventrikül fonksiyonlarına etkisi. IX. Ulusal Böbrek Hastalıkları, Diyaliz ve Transplantasyon kongresi, 01-04 Ekim 1992, Ürgüp.
  • E42..Akbay E, Gönenç F, Dalva I, Güneş Z, Boran M,Çetin S.Hemodializ için yapılan vasküler girişimler. VIII. Ulusal Böbrek Hastalıkları, Diyaliz ve Transplantasyon kongresi, 12-14 haziran 1991, İstanbul
  • E43. Boran M, Akbay E, Güneş Z, Karahan M, Dalva I, Gönenç F. Hemodiyaliz hastalarında nazal st.aureus taşıyıcılığı ve tedavisi. VIII. Ulusal Böbrek Hastalıkları, Diyaliz ve Transplantasyon kongresi, 12-14 Haziran 1991, İstanbul
  • E44. Boran M, Gönenç F, Akbay E, Yazıcıoğlu A, Çetin S. Hemodiyaliz hastalarında r-Hu EPO uygulaması IV mi, SC mı? . VIII. Ulusal Böbrek Hastalıkları, Diyaliz ve Transplantasyon kongresi, 12-14 haziran 1991, İstanbul
  • E45. Boran M, Gönenç F, Yazıcıoğlu, Özgür S, Çetin S. Hemodializ hastalarında serum beta2 mikroglogulin düzeyi ve değişik membranların etkinliği. VII Ulusal Böbrek Hastaları ve Transplantasyon kongresi; 7-10 kasım, 1990, Kuşadası
  • E46. Boran M, Gönenç F, Güneş z, Akbay E, Çetin S. Hemodializ hastalarındaki aneminin düzeltilmesinde Recombinant Human Erythropoietin tedavisinin yeri. VII Ulusal Böbrek Hastaları ve Transplantasyon kongresi; 7-10 kasım, 1990, Kuşadası.

KİTAPLAR

  • Boran M, Dalva I, Yazicioğlu A, Cetin S Subcutaneous versus intravenous recombinant human erythropoietin administration in hemodialysis patients. In Skizuo Yoshikowa (editor). Erythropoietin Literature: Its QOL in the Medical field and economic Effectiveness, Tokyo, Kirin Brewery Co Ltd, Life Science Co Ltd,pp161-162,1995.

DİĞER

ÖDÜLLER
  • Türkiye Bilimsel Ve Teknik Araştırma Kurumu(TUBİTAK) Uluslar Arası Bilimsel Yayın Teşfik Değerlendirilme Komisyonu Ödülü. 15.12.1993
  • Organ Nakli Kuruluşları Koordinasyon Derneği IV Kongresi, Prof Dr Eren-Uğur Erken’’ İmmünolojik Çalışma Ödülü’’- Balcı M, Gariboğluş, Özatik M A, Boran M, Küçükaksu S, Gönenç F. CD4+CD25+Regulatuar T Hücreleri Böbrek Ve Kalp Transplantların Takibinde İmmun Tolerans için bir gösterge olabilir (mi?). 15-19 Eylül 2004
  • 17 Temmuz 1990 tarihinde Suudi Arabistan’da Hac farizası sırasında meydana gelen müessif kaza nedeniyle yaralanan vatandaşlarımızı yurda getirmek için Sağlık Bakanlığı tarafından oluşturulan ekipte görevinizi büyük bir özveri ile gerçekleştirdiğiniz gözlenmiş ve övgüye değer bulunmuş nedeni ile T.C. Sağlık Bakanlığı, Sağlık Bakanı Halil Şıvgın, Özel Teşekkür Belgesi -17.7.1990
  • Gerçekleştirilen Organ Alımı, Transplantasyon Hazırlığı ve Takibi İçin T.C. Sağlık Bakanlığı Özel Takdirnamesi -22.12.1997
  • Organ Nakli Kuruluşları Koordinasyon Derneği kuruluşundaki katkılarından dolayı teşekkür belgesi, Mayıs 1994.
ATIFLAR
  • 1. Han G, Zhang J, Lu S, Li Y, Yu X. Risk factors associated with acute renal failure (ARF) in patients after cardiac surgery Chinese Journal of Emergency Medicine 2006; 15 (7); 625–628.
  • 2. Markewitz A, Lante W. Organ failure in cardiosurgical intensive care medicine | [Organversagen in der herzchirurgischen intensivmedizin]. Deutsche Medizinische Wochenschrift 2006; 131 (44): 2485–2488.
  • 3. Mertin S. Perioperative outcome evaluation of total spinal anesthesia combined with intrathecal morphine and general anesthesia versus general anasthesia for cardiac surgery. University of Manitoba. Canada 2006
  • 5. Oberhoffer M, Weis M, Eifert S, Kaczmarek I, Mair H, Schmoeckel M.ReicharB, Vicol C. Prospective randomized study of preoperative intraaortic balloon counterpulsation in high-risk coronary artery bypass grafting patients. Thorac cardiovasc Surg 2006; 54 - MP_25. DOI: 10.1055/s-2006-925656
  • 6. Buron F, Pinck E, Blaffart F, Larbuisson R, Roediger L, Senard M, Damas P, Preiser JC, Lamy M. Risk factors for renal dysfunction after cardiac surgery. Acta Anaesthesiologica Belgica 2007; 58 (1):65.
  • 7. Ennker J, Bories J, Albert A. Epidemiologie der Nierenerkrankung. Clin Res Cardiol Suppl 2007 [Sonderheft 1]2:S6–S7. Editorial. DOI 10.1007/s11789-006-0029-6.
  • 8. Brown JR, Cochran RP, Leavitt BJ, Dacey LJ, Ross CS, MacKenzie TA, Kunzelman KS, Kramer RS, Hernandez HJr, Helm RE, Westbrook BM, Dunton RF, Malenka DJ, O'Connor GT. For the Northern New England Cardiovascular Disease Study Group Multivariable prediction of renal insufficiency developing after cardiac surgery. Circulation 2007; 116 (11 SUPPL. 1): 139–143.
  • 9. Palomba H, De Castro I, Neto ALC, Lage S, Yu L. Acute kidney injury prediction following elective cardiac surgery: AKICS Score. Kidney International 2007; 72 (5): 624–631.
  • 10. Zukowski M, Bohatyrewicz R, Krawczyk AA. Factors Influencing Serum Creatinine Level in Kidney Recipients in a Multivariate Analysis. Transplantation Proceedings 2007; 39 (9): 2724–2726.
  • 11. Regner KR. Epidemiology of acute kidney injury after cardiac surgery: An update. Journal of Organ Dysfunction 2007; 3 (4): 232–239. DOI:10.080/17471060701236935
  • 12. Dabrowski W. Changes in intra-abdominal pressure and central venous and brain venous blood pressure in patients during extracorporeal circulation Medical Science Monitor 2007; 13 (12): CR548-CR554.
  • 13. Lee HL, Kim J, Kim H, Park D, Seo I, Song S, Kim S, Lee D, Jee D. Risk factors of acute renal failure after colorectal surgery. Yeungnam Univ. J. of Med. 2007; 24(2):275-286.
  • 14. 孙世仁, 宁晓暄, 陈威, 王汉民, 于艳, 景明菲 - 实用医学杂志. 自动腹膜透析治疗心脏术后急性肾功能衰竭 24 例. 2007 syyxzz.com. 2007;23(17):2664-2666.
  • 15.ЛГ Мондоев, ЛС Бирюкова , Применение карнитина у больных с хронической почечной недостаточностью, находящихся на лечении программным гемодиализом (Обзор) - Нефрология и диализ,vol 9 (4) pp 391-394, 2007
  • 16. E Dursun, B Dursun, G Suleymanlar, T Ozben - Effect of haemodialysis on the oxidative stress and antioxidants in diabetes mellitus - Acta diabetologica, 42(3):123-128, 2005
  • 17. Blot SI, Vandijck DM, Hoste EA. Trends in mortality in coronary artery bypass graft patients with acute renal failure. Critical Care Medicine 2008; 36 (2). 656.
  • 18. ZI Khalpey, RB Ganim, JD Rawn - Cardiac surgery in the adult, 2008 Postoperative care of cardiac surgery patients.
  • 19. Ostermann M. Acute renal failure in the surgical patient. Renal Failure and Replacement Therapies Competency-Based Critical Care. Editor: Blakeley S. Springer. 2008;33-37. ISBN: 978-1-84628-936-1 (Print) 978-1-84628-937-8 (Online). London UK.
  • 20. Hoste EAJ, Cruz DN, Davenport A, Mehta RL, Piccinni P, Tetta C, Viscovo G, Ronco C. The epidemiology of cardiac surgery-associated acute kidney injury International Journal of Artificial Organs 2008; 31 (2): 158–165.
  • 21. Elíasdóttir SB, Klemenzson G, Torfason B, Valsson F. Brain natriuretic peptide is a good predictor for outcome in cardiac surgery. Acta Anaesthesiologica Scandinavica 2008; 52 (2): 182–187.
  • 22. Barr LF, Kolodner K. N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery Critical Care Medicine 2008; 36 (5): 1427–1435.
  • 23. Yeo KK, Li Z, Yeun JY, Amsterdam E. Severity of Chronic Kidney Disease as a Risk Factor for Operative Mortality in Nonemergent Patients in the California Coronary Artery Bypass Graft Surgery Outcomes Reporting Program. American Journal of Cardiology 2008; 101 (9): 1269–1274.
  • 24. Brown JR, Cochran RP, MacKenzie TA, Furnary AP, Kunzelman KS, Ross CS, Langner CW, Charlesworth DC, Leavitt BJ, Dacey LJ, Helm RE, Braxton JH, Clough RA, Dunton R, O'Connor GT. For the Northern New England Cardiovascular Disease Study Group. Long-Term Survival After Cardiac Surgery is Predicted by Estimated Glomerular Filtration Rate Ann Thoracic Surgery 2008;86(1):4–11.
  • 25 Goldberg R, Dennen P. Long-Term Outcomes of Acute Kidney Injury Advances in Chronic Kidney Disease 2008; 15 (3): 297–307.
  • 26. Jia M, Zhou Y, Shao JJ, Luo ZM, Zhou X, Song TY, Jia SJ. Analysis of the associated complications with circulatory support device. Chinese Journal of Emergency Medicine 2008; 17 (8): 867–869.
  • 27. Vermeer H, Teerenstra S, de Sévaux RGL, van Swieten HA, Weerwind PW. The effect of hemodilution during normothermic cardiac surgery on renal physiology and function: A review Perfusion 2008; 23 (6): 329–338.
  • 28.Eritropoetin Tedavisi Alan Çocuk Periton Diyalizi Hastalarında Karnitin Supplemantasyonu'nun Anemiye Etkileri. AÜTFÇ Sağlığı – Türk Nefroloji,Dializ Transplantasyon dergisi,Official Journal of the Turkish Society of Nephrology 2003;12 (1)41-47
  • 29. Rodríguez Benítez C DE.Formación continuada Fisiopatología y tratamiento de la anemia en la insuficiencia renal crónica terminal Therapeutica,vol1(14)pp70-78- revistaseden.org
  • 30. Weerasinghe DP, Wolfenden HD, Yusuf F. Coronary artery bypass graft surgery in New South Wales Australia. Public Health 2008;122(2):151-160. http://www.publichealthjrnl.com/article/S0033-3506(07)00135-7/abstract.
  • 31. Bahar I, Akgul A, Demirbag AE, Altinay L, Thompson LO, Boran M, Özatik MA, Birincioglu L. Open heart surgery in patients with end-stage renal failure: Fifteen-year experience Journal of Cardiac Surgery 2009; 24 (1): 24–29.
  • 32. C Koşan, L Sever, S Çalışkan, Ö Kasapçopur, N Arısoy,Çocuk periton diyalizi hastalarında karnitin tedavisinin eritrosit ozmotik frajilitesine etkisi
  • 32. L Takouli, D Hadjiyannakos, P Metaxaki et al Vitamin E-coated cellulose acetate dialysis membrane: long-term effect on inflammation and oxidative stress- Renal failure; 32 (3) : 287-293, 2010
  • 33. Tuladhar SM, Püntmann VO, Soni M, Punjabi PP, Bogle RG. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass J Cardiovasc Pharm 2009;53 (3):261–266.
  • 34. Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term Risk of Mortality and Other Adverse Outcomes After Acute Kidney Injury: A Systematic Review and Meta-analysis American Journal of Kidney Diseases 2009; 53 (6): 961–973.
  • 35. Felicio ML, de Andrade RR, Castiglia YMM, Silva MAM, Vianna PTG, Martins AS. Cystatin C and glomerular filtration rate in the cardiac surgery with cardiopulmonary bypass | [Cistatina C e taxa de filtração glomerular em cirurgia cardíaca com circulação extracorpórea]. Brazilian Journal of Cardiovascular Surgery 2009; 24 (3): 305–311.
  • 36. Reynvoet E, Vandijck DM, Blot SI, Dhondt AW, De Waele JJ, Claus S, Buyle FM, Vanholder R, Hoste EAJ. Epidemiology of infection in critically ill patients with acute renal failure Critical Care Medicine 2009; 37 (7): 2203–2209.
  • 37. Huffmeyer JL, Mauermann WJ, Thiele RH, Ma JZ, Nemergut EC. Preoperative Statin Administration Is Associated With Lower Mortality and Decreased Need for Postoperative Hemodialysis in Patients Undergoing Coronary Artery Bypass Graft Surgery J Cardiothoracic and Vascular Anesthesia 2009; 23 (4): 468–473.
  • 38. Liangos O, Tighiouart H, Perianayagam MC, Kolyada A, Han WK, Wald R, Bonventre JV, Jaber BL. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers 2009; 14 (6): 423–431.
  • 39. Machado MDN, Miranda RC, Takakura IT, Palmegiani E, Dos Santos CA, Oliveira MA, Mouco OM, Hernandes ME, Lemos MA, Maia LN. Acute kidney injury after on-pump coronary artery bypass graft surgery. |[Lesión renal aguda post-revascularización del miocardio con circulación extracorpórea] Arquivos Brasileiros de Cardiologia 2009; 93 (3): 230–235+242–247+247–252.
  • 40. Liangos O, Kolyada A, Tighiouart H, Perianayagam MC, Wald R, Jaber BL. Interleukin–8 and acute kidney injury following cardiopulmonary bypass: A prospective cohort study. Nephron - Clinical Practice 2009; 113 (3):c148-c154.
  • 41. Bagry HS, Carli F. Role of statins in peri-operative medicine. Current Drug Targets 2009; 10 (9): 850–857.
  • 42. Tirilomis T, Tempes T, Waldmann-Beushausen R, Ballat C, Bensch M, Schoendube FA. Histological changes in neonatal kidneys after cardiopulmonary bypass and deep hypothermic circulatory arrest. Thoracic and Cardiovascular Surgeon 2009; 57(1):7–9.
  • 42. B Akcora, ME Altug, T Kontas et al The protective effect of darbepoetin alfa on experimental testicular torsion and detorsion injury- International Journal of Urology 14(9) : 846-850, 2007
  • 43. Metz LI, LeBeau ME, Zlabek JA, Mathiason MA. Acute renal failure in patients undergoing cardiothoracic surgery in a community hospital. Wisconsin Medical Journal 2009; 108 (2):109–114.
  • 44. Mojtahedzadeh, M., Sabzghabaee, A.M., Ganji, M.R., Razavi, P. Risk factors and prognostic factors of acute renal failure in patients admitted to an intensive care unit, Tehran-Iran Iranian Journal of Pharmacology and Therapeutics2009; 8 (2), pp. 87-91.
  • 45. 贾明, 周晔, 邵涓涓, 罗智敏, 周啸, 宋铁鹰, 贾士杰 - 中华急诊医学杂志. 机械循环辅助的相关并发症分析. 2009.
  • 46. TJC Neiva, AL Benedetti, S Tanaka et.al Determination of serum aluminum, platelet aggregation and lipid peroxidation in hemodialyzed patients - Brazilian Journal ofMedical and Biological Research;35(3) 2002
  • 47. 闫晓蕾, 李群, 侯晓彤, 李小密, 邵涓涓, 贾明, 万久贺… - 中华医学杂志. 肾功能分级在成人心脏术后肾功能衰竭的应用. 2009 - cqvip.com. Yan X, Li Q, Hou X, Li X, Shao J, Jia M, Wan J, Jia S. Postoperative acute renal failure in adult patients with cardiac surgery: evaluation of the RIFLE classification.National Medical Journal of China 2009; 89(25):54-65. DOI: 10.3760/cma.j.issn.0376-2491.2009.25.012
  • 48. 肾功能损伤分级系统在成人心脏术后的应用 闫晓蕾, 侯晓彤, 陈英, 杨勇, 万久贺, 贾明… - 中华胸心血管外科 …, 2009 - 万方数据资源系统. Yan X, Hou X, Che Y, Yang Y, Wan J, Jia M, Jia S, Acute renal failure after cardiac surgery in intuit in adult patients : evaluation of the ARF-specific scoring systems. Chınese Journal Of Thoracıc And Cardıovascular Surgery. 2009, 25(3). doi: 10.3760/cma.j.issn.1001-4497.2009.03.011
  • 49. Cais DP. Nosocomial infections in cardiac patients under hemodialysis procedure in an intensive care unit (thesis). Sao Paulo, Brasil: Escola de Enfermagem, Universidade de Sao Paulo; 2009. Orientador: Ruth N Turrini T
  • 50. Felicio ML, Andrade RR, Castiglia YMM, Silva MAM, Vianna PTG, Martins AS. Cistatina C e taxa de filtraçao glomerular em cirurgia cardiaca com circulaçao extracorporea. Rev Bras Cir Cardiovasc. 2009;24(3);305-11.
  • 51. Turrini RNT. Infecçoes hospitalares em pacientes cardiopatas sob procedimento hemodialialitico em unidade de terapia intensiva. Dissertaçao apresentada a Escola de Enfermagem da Universidade de Sao Paulo para obtençao do titulo de mestre em Enfermagem. Area de Concentraçao: Programa de Pos-Graduaçao em Enfermagem na Saude do Adulto. Sao Paolo. 2009. Finishing Thesis.
  • 52. Houser SL. External evidence of open-heart surgery. The Operated Heart at autopsy. 2009.1-8. Humana Press ISBN 978-1-60327-808-9.
  • 53. M Mydlík, K Derzsiová, O Rácz et al - Vitamin E-coated dialyzer and antioxidant defense parameters: three-month study - Seminars in Nephrology; 24 (5) : 525-531 , 2004
  • 54. Hennessy SA, Lapar DJ, Stukenborg GJ, Stone ML, Mlynarek RA, Kern JA, Ailawadi G, Kron IL. Cardiac catheterization within 24 hours of valve surgery is significantly associated with acute renal failure. Journal of Thoracic and Cardiovascular Surgery 2010; 140 (5): 1011–1016. (SCI)
  • 55. Ji QA, Mei YQ, Wang XS, et al. Risk factors for failure of continuous veno-venous hemodialysis in the treatment of acute renal failure following cardiac surgery PERFUSION-UK 2010; 25 (5): 337–342.(SCIE)
  • 56.R Mehrotra, JD Kopple Nutrition and anemia in end-stage renal disease. Nutritional Management of Renal Diseas, 2004 - books.google.com
  • 57. A Gönenç, Y Atak, MN Orman, B Simsek Lipid peroxidation and antioxidant systems in hemodialyzed patients- Dialysis & Transplantation;31(2):88-96 2002
  • 58. 关静, 杨瑛, 彭国辉, 刘献成, 金小桦 - 中国临床实用医学. CRRT 治疗心脏直视术后急性肾损伤的临床体会. 2010-cqvip.com
  • 59. CT Kumarappan, SC Mandal -Polyphenolic extract of Ichnocarpus frutescens attenuates diabetic complications in streptozotocin-treated diabetic rats- Renal failure;30(3):307-322, 2008
  • 60. Schneider CA. Veränderungen der zerebralen Hämodynamik während operativer Myokardrevaskularisation ohne Herz- Lungen- Maschine (Off- Pump) Inaugural- Dissertation zur Erlangung des Doktorgrades der Medizin Der Medizinischen Fakultät der Universität Regensburg. 2010. Finishing thesis. German. CA Schneider - 2010 - epub.uni-regensburg.de
  • 61. Laine T. Admissiolampotilan vaikitus toipumiseen tays sydankeskus oy:teho-osastolla. Syventavien opintojen kirjalinen työ. Tampereen yliopisto. Laaketieteen laitos. Huhtikuu. 2010. http://tutkielmat.uta.fi/pdf/gradu05118.pdf.
  • 62. 左心室辅助装置在心脏术后低心排综合征的临床应用 马幸生, 杨双强 - 实用医院临床杂志, 2011 - 万方数据资源系统. Ma X, Yang S. Clinical application of left ventricular assist device in postcardiotomy low cardiac output syndrome. PRACTICAL JOURNAL OF CLINICAL MEDICINE. 2011, 08(5). doi: 10.3969/j.issn.1672-6170.2011.05.003
  • 62. A Debska-Slizien, A Owczarzak, D Kunicka, E Krol et al, Article Specifications,2011
  • 63. Weir, M.R., Aronson, S., Avery, E.G., Pollack Jr., C.V. Acute kidney injury following cardiac surgery: Role of perioperative blood pressure control American Journal of Nephrology 2011; 33 (5), pp. 438-452.
  • 64. Yang XH, Sun ZJ, Zheng LQ, Jia YC, Dong LL. The risk factors for worsening renal function in patients with chronic renal failure. Chin J Intern Med July 2011, 50(7):568- 570
  • 65. Johnson, R.F., Gustin, J. Acute renal failure requiring renal replacement therapy in the intensive care unit: Impact on prognostic assessment for shared decision making Journal of Palliative Medicine 2011; 14 (7), pp. 883-889.
  • 65. J Borawski, K Pawlak, B Naumnik et al Relations between oxidative stress, hepatocyte growth factor, and liver disease in hemodialysis patients - Renal failure;24(6): 825-837, 2002
  • 66. A Çeliker, B Giray, T Başay, L Öner - The effect of recombinant human erythropoietin on serum selenium levels in hemodialysis patients - Journal of trace elements in medicine and biology ;15 (4):215-220, 2001
  • 66. Jarvela, K., Maaranen, P., Harmoinen, A., Huhtala, H., Sisto, T. Cystatin C in diabetics as a marker of mild renal insufficiency after CABG Annals of Thoracic and Cardiovascular Surgery 2011; 17 (3), pp. 277-282.
  • 67. Nielsen, D.V., Hjortdal, V., Larsson, H., Johnsen, S.P., Jakobsen, C.-J. Perioperative aminoglycoside treatment is associated with a higher incidence of postoperative dialysis in adult cardiac surgery patients Journal of Thoracic and Cardiovascular Surgery2011; 142 (3), pp. 656-661.
  • 68.左旋肉碱对腹透患者贫血的治疗作用徐家云, 郭志玲, 毛永琰, 贾国强, 董少卿, 许德英… - 中原医刊, 2006 - 万方数据资源系统摘要: 目的观察左旋肉碱对慢性肾衰(CRF) 腹透患者贫血的治疗作用. 方法将Hb< 90g/L 接受r- HuEPO 治疗的16 例腹透病人, 随机分为A, B 两组; 将Hb> 90g/L, 不接受r-HuEPO 治疗的12 .例腹透病人, 随机分为C, D 两组. A, C 两组给予左旋肉碱治疗, B, D 两组给予等体积生理盐水
  • 69. 提运幸, 潘征夏, 吴春, 王刚, 李洪波, 李勇刚, 安永… - 中国中西医结合. 黄芪注射液对婴儿先天性心脏病体外循环术后肾损伤的干预作用. 2011 - cqvip.com. Intervention of Astragalus injection on the kidney injury after cardiopulmonary bypass of infants wiyh congenital heart disease. Chinese Journal of Integrated Traditional and Western Medicine 2011;31(5). http://d.wanfangdata.com.cn/periodical_zxyjh201105010.aspx
  • 70. 1113 例心脏瓣膜置换手术后急性肾损伤的临床分析 衡艳艳, 方艺, 钟一红, 滕杰, 邹建洲, 王春生, 刘岚… - 中华肾脏病杂志, 2011 - cjn.org.cn. Heng Y, Fang y, Zhong Y, Teng J, Zou J, Wang C, Liu D, Ding X. Clinical analysis of acute kidney injury in 1113 patients after cardiac valve replacement surgery. Chinese Journal of Nephrology 2011;27(3)181-185. DOI:10.3760/cma.j.issn.1001-7097.2011.03.10
  • 71. Care C. Postoperative care of cardiac surgery patients. Cardiac Surgery in Adult 2011. McGraw-Hill Professional
  • 72. 急性肾损伤与心胸外科手术的联系 李青, 周竹 - 国际泌尿系统杂志 ISTIC, 2011 - 万方数据资源系统. International Journal of Urology and Nephrology 2011,31(6) doi: 10.3760/cma.j.issn.1673-4416.2011.06.035 http://d.wanfangdata.com.cn/periodical_gwyx-mnxt201106035.aspx
  • 73. Bakaeen FG, Stephens EH, Chu D, Holman W, Vaporciyan AA, Merrill WH, Gruver FL. Perceptions regarding cardiothoracic surgical training at Veterans Affairs hospitals. The Journal of Thoracic and Cardiovascular Surgery 141(5):May 2011, Pages 1107–1113. http://dx.doi.org/10.1016/j.jtcvs.2011.01.043,
  • 74.LPınto Uso de carnitina em terapia nutricional Use of carnitine in nutritional therapy- Food Nutr,vol 25pp113-134, 2003 - revistanutrire.org.br
  • 74.F Fabrizi, V Dixit, P Messa, P Martin ,Interferon monotherapy of chronic hepatitis C in dialysis patients: meta‐analysis of clinical trials - Journal of Viral Hepatitis,vol 15 (2) pp79-88, 2008
  • 75. Karkouti K. Transfusion and risk of acute kidney injury in cardiac surgery. Br J Anaesth 2012;109(suppl1):i29-i38.
  • 76. Mancini E, Caramelli F, Ranucci M, Sangiorgi D, Reggiani LB, Frascaroli G, Zuchelli A, Bellasi A, Santoro A. Is time on cardiopulmonary bypass during cardiac surgery associated with acute kidney injury requiring dialysis? Hemodialysis International 16(2):252–258, April 2012. DOI: 10.1111/j.1542-4758.2011.00617.x
  • 77. Torrati FG, Dantas RAS. Extracorporeal circulation and complications during the immediate postoperative period for cardiac surgery. Acta Paul Enferm. 2012;25(3):340-5.
  • 78. F Fabrizi, S Bunnapradist, P Martin Treatment of hepatitis C in potential kidney and heart transplant patients- Clinics in liver disease, 2005 vol 9 (3): 487-503 doi:10.1016/j.cld.2005.05.006
  • 79. Molnar AO, Parikh CR, Sint K, Coca SG,Koyner J, Patel UD, Butrymowicz I, Shlipak M, Garg A. Association of Postoperative Proteinuria with AKI after Cardiac Surgery among Patients at High Risk CJASN ePress. Clin J Am Soc Nephrol 7: ccc–ccc, 2012. doi: 10.2215/CJN.13421211 Published on September 13, 2012.
  • 80. Onuigbo MAC. Renoprevention: A New Concept for Reengineering Nephrology Care—An Economic Impact and Patient Outcome Analysis of Two Hypothetical Patient Management Paradigms in the CCU. Renal Failure 2012; doi: 10.3109/0886022X.2012.741644.
  • 81. Cartin-Ceba R, Kashiouris M, Plataki M,Kor DJ, Gajic O, Casey ET. Risk Factors for Development of Acute Kidney Injury in Critically Ill Patients: A Systematic Review andMeta-Analysis of Observational Studies. Critical Care Research and Practice 2012; Article ID 691013, 15 pages. doi:10.1155/2012/691013.
  • 82. Madenci AL, Thiagarajan RR, Stoffan AP, Emani SM, Rajagopal SK, Weldon CB. Characterizing peritoneal dialysis catheter use in pediatric patients after cardiac surgery. J Thorac Cardiovasc Surg 2013; 334-338 http://dx.doi.org/10.1016/j.jtcvs.2012.10.009 http://www.sciencedirect.com/science/article/pii/S0022522312012494
  • 83. CH Liu, JH Kao, Treatment of hepatitis C virus infection in patients with end‐stage renal disease, Journal of gastroenterology and hepatology,vol 26(2)pp228-239, 2011
  • 84.J Wang, GJ Xiang, BX Liu Effect of alpha 2b interferon on inducement of mIL-2R and treatment of HCV in PBMC from patients with chronic viral hepatitis C– World Journal of Gastroenterology 9(4)pp751-754, 2003
  • 84. M Mydlík, K Derzsiová, O Rácz, et al. Antioxidant therapy by oral vitamin E and vitamin E-coated dialyzer in CAPD and haemodialysis patients- Prague medical report;107(3):354-364 , 2006
  • 85. LK Dajani, E Paus, DJ Warren Development of a rapid and sensitive immunofluorometric assay for glutathione S-transferase A- Clinical chemistry, vol 47(5) pp 867-873,2001
  • 86. Wetz AJ. Evaluierung, Validierung und Anwendung eines Scores zur Stratifizierung des Risikos akuter Nierenfunktionsstörungen nach kardiochirurgischen Operationen. 2014. PhD Thesis. Göttingen ,Georg -August Universität, Diss, 2013.
  • 87. Twal M, Kiefer P, Salameh A, Schnabei J, Ossmann S, Salisch S, Kramer K, Sobiraj A, Kostelka M, Mohr FW, Dhein S. Reno-protective effects of epigallocatechingallate in a small piglet model of extracorporeal circulation. Pharmacological Research 2012; 67(1) 68-78.
  • 88. Gurbuz HA, Durukan AB, Salman N, Tavlasoglu M, Durukan E, Ucar HI, Yorgancioglu C. Hydroxyethyl starch 6%, 130/0.4 vs. a balanced crystalloid solution in cardiopulmonary bypass priming: a randomized, prospective study. Journal of Cardiothoracic Surgery 2013; 8(71):1-5. http://www.cardiothoracic surgery.org/content/8/1/71
  • 88.E Sárváry, Z Gerlei, E Dinya, E Tóthet al Hepatitis C infected hemodialysis and renal transplant patients with elevated α-glutathione S-transferase have increased risk for liver damage- Interventional Medicine and Applied Science vol 2(2)pp70-76, 2010
  • 89. Jasulaitis D. Einfluss von Levosimendan auf den intensivmedizinischen Verlauf und das 180-Tage-Überleben bei Patienten mit mechanichen Herzunterstützungsverfahren bei schwerem Postkardiotomieherzversagen. Zur Erlangung des akademischen Grades Doctor medicinae. Vorgelegt der Medizinichen Fakultat. Charite-Universitatsmedizin Berlin. Aus der für Anasthesiologie mit Schwerpunkt operative Intensivmedizin der Medizinischen Fakultat Charite-Universitatsmedizin Berlin. Marz 2013.
  • 89.CH Liu, JH Kao Treatment of Hepatitis C Virus Infection in Patients with End-Stage Renal Disease: Progress and Challenges - Acta Nephrologica,26(4):173-187, 2012
  • 90. Stads S, Fortrie G, van Bommel J, Zietse R, Betjes MGH. Impaired Kidney Function at Hospital Discharge and Long-Term Renal and Overall Survival in Patients Who Received CRRT. CJASN 2013; April doi: 10.2215/ CJN.06650712.
  • 91. Schneider AG, Bellomo R, Bagshaw SM, Glassford NJ, Lo S, Jun M, Cass A, Gallagher M. Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis. Intensive Care Medicine June 2013, Volume 39, Issue 6, pp 987-997. DOI : 10.1007/s00134-013-2864-5
  • 92. Litton E, Delaney A. Prophylactic intraaortic balloon counterpulsation in high-risk cardiac surgery: a survey of opinion and current practice. HSR Proc Intensive Care Cardiovasc Anesth 2013;5(1):33-39. www.ncbi.nlm.nih.gov/pmc/articles/PMC3670717/
  • 93. Onuigbo MAC. Evidence of the syndrome of rapid onset end-stage renal disease (SORO-ESRD) in the acute kidney injury (AKI) literature – preventable causes of AKI and SORO-ESRD – a call for re-engineering of nephrology practice paradigms. Renal Failure, July 2013, Vol. 35, No. 6: Pages 796-800 http://informahealthcare.com/ doi/pdf/10.3109/0886022X.2013.800459.
  • 94. Susantitaphong P, Perianayagam MC, Tighiouart H, Kouznetsov D, Liangos O, Jaber BL. Urinary α- and π-glutathione s-transferases for early detection of acute kidney injury following cardiopulmonary bypass. Read More: http://informahealthcare.com/ doi/abs/10.3109/1354750X.2013.781678
  • 95. Onuigbo MAC. Renoprevention: A new concept for reengineering nephrology care-An economic impact and patient outcome analysis of two hypothetical patient management paradigms in the CCU. Renal Failure 2013;35:23-28. DOI: 10.3109/0886022X.2012.741644.
  • 96. Santos ES. N-acetilcisteina na prevançao de lesao renal aguda em pacientes com doença renal cronica submetidos a cirurgia eletiva de revascularizaçao miocardica: estudo prospectivo, randomizado e duplo-cego / Eduesley Santana Santos.—Sao Paolo, 2013. Orientador: Jose Jayme Galvao de Lima. USP/FM/DBD-179/13
  • 97. Aggeli C, Felekos I, Poulidakis E, Koutagiar I, Venieri E, Stefanadis C. (2013). Coronary Artery Bypass Grafting and Biomarkers. Biomarkers in Cardiovascular Diseases, 164.
  • 98. 周瑛,柴华旗,宋丹. 心血管术后急性肾损伤26例. 实用临床医药杂志. 2013年第17卷第1. Zhou Y, Song D, Chai H. Clinical summary of 26 patients with acute kidney injury after cardiovascular surgery. Journal of Clinical Medicine in Practice. 2013;17:15-17. DOI.10.7619/犼犮犿狆.201315033.
  • 99. Aydın S, Dogra S, Delrio M. Acute kidney injury. Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care 2014: 3257-3277.
  • 100. Aronson S, Phillips-Bute B, Stafford-Smith M, Fontes M, Gaca J, Mathew JP, Newman MF. The Association of Postcardiac Surgery Acute Kidney Injury with Intraoperative Systolic Blood Pressure Hypotension. Anesthesiology Research and Practice Volume 2013 (2013), Article ID 174091, 7 pages
  • 101.N Crofts, J Kaldor, SC Thompson [KİTAP] Epidemiology of the hepatitis C virus- 1999 - mbsonline.gov.au
  • 102.YH Abacioglu, F Bacaksiz, IH Bahar et al-Molecular evidence of nosocomial transmission of hepatitis C virus in a haemodialysis unit ;Eur Jour of Clin Microbiol and Infect Dis ;vol 19(3) : 182 - 86 , 2000
  • 103. Martucci AF, Castiglia YMM. Renal function after coronary bypass graft using dexmedetomidine. Open Journal of Anesthesiology 2013;3:421-426 http://dx.doi.org/10.4236/ojanes.2013.39088
  • 104. Azau A, Markowicz P, Corbeau JJ, Cottineau C, Moreau X, Baufreton C, Beydon L. Increasing mean arterial pressure during cardiac surgery does not reduce the rate of postoperative acute kidney injury. Perfusion 2014;29(2):doi:10.1177 /026765911452331
  • 105. Molnar AO, Parikh CR, Coca SG, Thiessen-Philbrook H, Koyner JL, Schlipak MG. Association between preoperative statin use and acute kidney injury biomarkers in cardiac surgical procedures. Ann Thorac Surg 2014; 97(6) 2081-2087. http://dx.doi.org/10.1016/j.athoracsur.2014.02.033
  • 106. AronsonS.Perioperative hypertansif emergensies. Curr Hypertens Rep 2014;16(448).2-8. http://link.springer.com/article/10.1007/s11906-014-0448-6#page-1
  • 107. Aydın S, Dogra S, DelRio M. Acute kidney injury. Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care 2014:3257-3277 Eds. Da Cruz EM, Ivy D, Jaggers J. Springer London. DOI:10.1007/978-1-4471-4619-3_174
  • 108. Ghonemy TA, Amro GM. Plasma neutrophil gelatinase-associated lipocalin (NGAL) and plasma cystatin C(CysC) as biomarker of acute kidney injury after cardiac surgery. Saudi J Kidney Dis Transpl 2014;25:582-8. http ://www .sjkdt.org/ text. Asp 201425/ 3/582 / 132194
  • 109. Akbari H, Nikkhah A, Alizadeh A. Evaluation of acute renal failure and its associated factors in heart surgery patients in Fatima Zahra Hospital, Sari, 2012. J Mazand Univ Med Sci 2014; 23(112) (Persian) http://jmums.mazums.ac.ir /files/site1 /user files 0d0bf0 / atinik1357-A-11-2502-1-9140c44.pdf
  • 110. Kim JD, Chee HK, Shin JK, Kim JS, Lee SA, Kim YH, Lee WS, Kim HY. Novel early predictor of acute kidney injury after opern heart surgery under cardiopulmonary bypass using plasma neutrophil gelatinase-associated lipocalin. Korean J Thorac Cardiovasc Surg 2014,47(3):240-248,http://dx.doi.org/10.5090/http://synapse.koreamed.org /search.phpwhere=aview&id /&code=1051KJTCS&vmode=FULL
  • 111. CM Ballantyne, A Corsini, MH Davidson et al, Risk for myopathy with statin therapy in high-risk patients. Archives of Internal Medicine vol 163(5) pp 553-564, 2003 doi:10.1001/archinte.163.5.553.
  • 112.D Williams, J Feely Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors, Clinical Pharmacokinetics April 2002, Volume 41, Issue 5, pp 343-370
  • 113.BA Golomb, MA Evans. Statin adverse effects, American Journal of Cardiovascular Drugs November 2008, Volume 8, Issue 6, pp 373-418
  • 114. J Noé, R Portmann, ME Brun, C Funk Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1,Drug metabolism and disposition, vol 35 (8) pp1308-1314, 2007
  • 115. SK Baker, MA Tarnopolsky Statin myopathies: pathophysiologic and clinical perspectives Clinical and investigative medicine, 2001 - epe.lac-bac.gc.ca
  • 116. MH Davidson Controversy surrounding the safety of cerivastatin Expert opinion on drug safety,vol1(3) pp 207-212, 2002
  • 117. F Fernández-Llimós, L Tuneu, MI Baena et al Morbidity and mortality associated with pharmacotherapy. Evolution and current concept of drug-related problems. Current Pharmaceutical Design, Vol 10(31) , Num December 2004 , pp. 3947-3967(21)
  • 118. CM Mastroianni, G d'Ettorre, G Forcina, M Lichtner et al Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia Aids, 2001 - LWW
  • 119. J Bruno-Joyce, JM Dugas Cerivastatin and gemfibrozil-associated rhabdomyolysisThe Annals of pharmacotherapy vol 35(9), pp1016-1019, 2001 doı:10.1345/aph1A116
  • 120. A Muscari, GM Puddu, P Puddu Lipid-lowering drugs: are adverse effects predictable and reversible? - Cardiology, 2002;97:115–121
  • 121. J Wu, Y Song, H Li, J Chen Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report European Journal of Clinical Pharmacology,December 2009, Vo65(12), pp 1169-1174
  • 122. SL Ravnan, C Locke, WP Yee et al Cerivastatin‐Induced Rhabdomyolysis: 11 Case ReportsThe Journal of Human Pharmacology and drug therapy vol 22(4)pp533-537, 2002
  • 123. J Finsterer Fibrat-/Statin-Myopathie Der Nervenarzt, February 2003, Vol 74(2),pp 115-122
  • 124. B Roca, B Calvo, R Monferrer Severe rhabdomyolysis and cerivastatin-gemfibrozil combination therapy The Annals of pharmacotherapy vol 36(4)pp730731, 2002 DOI 10.1345/APH.1A383
  • 125. N Shibata, K Jishage, M Arita, M Watanabe, Y Kawase et al, Regulation of hepatic cholesterol synthesis by a novel protein (SPF) that accelerates cholesterol biosynthesisThe FASEB journal,2006 vol20(14)pp2642-2644
  • 126. F Hendriks, JP Koman et al Massive rhabdomyolysis and life threatening hyperkalaemia in a patient with the combination of cerivastatin and gemfibrozil. Nephrology Dialysis Transplantation vol16(12)pp2418-2419, 2001
  • 127. EG Bliznakov Coenzyme Q10, lipid-lowering drugs (statins) and cholesterol: a present day Pandora's box The Journal of the American Nutraceutical Association, 2002
  • 128. N Tomiyama, N Yasuda, C Iwano et al Flow Cytometrıc Evaluatıon Of Synergıstıc Pro‐Apoptotıc Effects Of Statıns And Clofıbrates In Im9 Human Lymphoblasts. Clinical and Experimental Pharmacology and Physiology, vol 34(9):876-880, 2007. doi 10.1111/j1440-1681.2007.04677x
  • 129. J Noe, R Portmann, ME Brun, C Funk Substrate dependent drug-drug interactions between gemfibrozil, fluvastatin and other OATP substrates on OATP1B1, OATP2B1 and OATP1B3 Drug Metabolism and Disposition, 2007 - ASPET
  • 130.ST Sinatra.Is cholesterol lowering with statins the gold standard for treating patients with cardiovascular risk and disease?Southern medical journal, 2003 - LWW
  • 131.MS Demirci, H Toz, F Yılmaz, et al- Risk factors and consequences of post‐transplant diabetes mellitus;Clinical Transplantation vol24(5):e170-e177, 2010
  • 132.M Günaydin, A Bedir, T Akpolat et al Prevalence of serum HGV-RNA among hemodialysis patients in Turkey - Infection,vol25(5):307-309, 1997
  • 133. HJ Milionis, TG Tsapoga, MS Elisaf et al. Another report of acute rhabdomyolysis following cerivastatin monotherapy Archives of internal Medicine 2001 vol 161 (21)-pp26-29 Am Med Assoc
  • 134.S Simpson Case reports of rhabdomyolysis associated with cerivastatin therapy. Archives of internal medicine, 2001 vol 161(21) pp2630 - Am Med Assoc
  • 135. N Marigliano, I Castellano, O Sanchez et al - Cerivastatin-induced rhabdomyolisis in a patient with diabetic nephropathy American journal of nephrology, 2001;21:85 doı 10.1159/000046227
  • 136. TH Yen, CT Chang, MS Wu, CC Huang Acute rhabdomyolysis after gemfibrozil therapy in a pregnant patient complicated with acute pancreatitis and hypertriglycerdemia while receiving continuous veno-venous hemofiltration therapy, Renal failure, 2003 vol25(1) pp139-143
  • 137. X Wu, J Wang, L Tan J Bui, E Gjerstad et.al, In Vitro ADME Profiling Using High-Throughput RapidFire Mass Spectrometry Cytochrome P450 Inhibition and Metabolic Stability Assays, Journal of Biomolecular Screening, 2012 vol17(6)pp761-772
  • 138. IH Kara, ME Yilmaz, Y Sari,et.al Seroprevalence and risk factors of HCV in dialysis patients in a university hemodialysis center of Southeast Anatolia, Turkey Dialysis and transplantation;30(11);748-755, 2001
  • 139.I Akpolat, E Özyilkan, F Karagöz et al - Hepatitis C in haemodialysis and nonuraemic patients: a histopathological study- International Urology and Nephrology, 30(3):349-355,1998
  • 140. NW Shammas, MJ Kapalis, J Deckert et al Effectiveness of Statin‐Gemfibrozil Combination Therapy in Patients With Mixed Hyperlipidemia: Experience of a Community Lipid Clinic and Safety Review from the literature,Official Journal of the American Society for Preventive Cardiology vol 6 (4) 189-194 , 2003
  • 141. M Gabay, A Lodolce Other reports of cerivastatin-induced rhabdomyolysis. Arch Intern Med. 2001;161(21):2629.
  • 142.AS Kalgutkar, JS Daniels. Carboxylic acids and their bioisosteres Metabolism, Pharmacokinetics and Toxicity of Functional groups:impact of chemical building blocks on Admet chapter 3, 2010 doi: 10.1039/9781849731102-00099- pubs.rsc.org
  • 143. V Todorov, R Boneva, P Ilieva, et.al High prevalence of hepatitis C virus infection in one dialysis center in Bulgaria- Nephron, 79(2):222-223,1998
  • 143. H Töz, D Nart, I Turan et al The acquisition time of infection: a determinant of the severity of hepatitis C virus‐related liver disease in renal transplant patients- Clinical Transplantation;23(5):723-731, 2009
  • 144.G Hayem Statins and muscles: what price glory? Joint Bone Spine, 2002 - Elsevier Masson
  • 145.A Parkinson, BW Ogilvie, BL Paris et al Human biotransformation Biotransformation. 2010 - books.google.com
  • 146. M Su, RS Hoffman, M Flomenbaum Cerivastatin and gemfibrozil-induced cardiac rhabdomyolysis- The American journal of forensic medicine and patology vol 23(3):305-306, 2002 - LWW
  • 147. AP Li.In Vitro Evaluation of Metabolic Drug–Drug Interactions: Scientific Concepts and Practical Considerations Pharmaceutical Sciences Encyclopedia: Drug , 2010 doi:10.10002/9780470571224pse054- Wiley Online Library
  • 148. T Akpolat CAPD: a control strategy to prevent spread of HCV infection in end-stage renal disease - Peritoneal dialysis international, 21(1):77-79,2001
  • 148.S Kahraman, R Yilmaz, G Genctoy,et.al Efficacy and safety of intravenous iron therapy for HCV-positive haemodialysis patients; Nephron Clinical practice vol 100:pp78-85, 2005
  • 149. L Etemad Statins and Potentially Interacting Medications: A Managed Care Perspective Preventive medicine in managed care—statin drug , 2004 American journal of management care- ajmc.com
  • 150. S Gabardi, C Cormier, J Cina et al Renal dysfunction associated with herbal remedies and dietary supplements, Nephrology Rounds, vol1(2):304:314,2003 - nephrologyrounds.org
  • 151. J Tormo Molina, I Gázquez Pérez et al Cerivastatina y gemfibrozilo: una combinación peligrosa Atención primariavol 28(6):438-440 ISSN 0212-6567, 2001
  • 152. MJR Ruiz, JAR Guerrero, AB Cordero, E de Teresa Empeoramiento de la taquicardia supraventricular tras la administración de adenosina: un efecto paradójico Med Clin (Barc), 2001
  • 153.G Hayem Statines et muscles: la rançon du succès Revue du rhumatisme, 2002 - Elsevier Masson
  • 154. HP Thomas, E Steinhagen-Thiessen Indications and contra-indications for statin treatment (primary and secondary prevention of hypercholesterolemia) HMG-CoA Reductase Inhibitors, 2002 - Springer
  • 155. AP Li In Vitro Evaluation of Metabolic Drug–Drug Interactions: Concepts and PracticeDrug-Drug Interactions in Pharmaceutical Development, 2008 - books.google.com
  • 156. AP Li 5 In vitro evaluation of metabolic drug–drug interactionsPredictive Toxicology in Drug Safety - books.google.com
  • 157. M Houston Coenzyme Q 10, Lipid-Lowering Drugs (Statins) and Cholesterol: A Present Day Pandora's Box freewebs.com
  • 158. E TISSOT, J CORNUZ, R DARIOLI, V MOOSER et.al Nature et fréquence des associations médicamenteuses susceptibles de majorer la toxicité musculaire des statinesJournal de Pharmacie Clinique vol 20(3)pp167-170, 2001
  • 159. S Frohlich, T Ryan, C Fagan Statin therapy associated with fatal rhabdomyolysis JICS, 2011 - journal.ics.ac.uk
  • 160 I Aursnes.Drugs that affect lipid metabolism Side Effects of Drugs Annual,vol 25 pp 529-532, 2002 - Elsevier
  • 161. PL SantaCruz, A González, ME León et al. Rabdomiólisis, insuficiencia renal aguda (IRA) y empleo combinado de cerivastatina con gemfibrozil. Una nueva evidencia Nefrologia,vol22(3), 2002 - revistanefrologia.com
  • 162. N Malliaraki, D Mpliamplias, M Kampa et.al Total and corrected antioxidant capacity in hemodialyzed patients- BMC Nephrology;4:4, 2003
  • 163. History of Drug DiscoveryJJ Li - Drug Discovery: Practices, Processes, and Perspectives Perfusion 2005; 20(6):317–322. (SCIE) (ISSN: 0267–6591).
  • 164.In vitro ADME profiling using high-throughput rapidfire mass spectrometry cytochrome P450 inhibition and metabolic stability assays
  • 165. S Frohlich T Ryan, C Fagan Statin therapy associated with fatal rhabdomyolysis - JICS,vol12(1) 2011 - journal.ics.ac.uk
  • 166. SB Kesh, K Sikder. K. Manna et al Promising role of ferulic acid, atorvastatin and their combination in ameliorating high fat diet-induced stress in mice - Life sciences, vol 92(17-19):938-949,2013
  • 167. H Fujino, S Shimada, I Yamada, M Hirano et al, Studies on the interaction between fibrates and statins using human hepatic microsomes Thieme Arzneimittelforschung 2003;53(10):701-707 doi:10.1055/s-0031-1299815
  • 168. S Bhoopathy, C Bode, V Naageshwaran Case Study 6. Transporter Case Studies: In Vitro Solutions for Translatable Outcomes Enzyme Kinetics in Drug Metabolizm Methods in molecular biology,vol 1113 pp485-511, 2014 doi:10.1007/978-1-62703-758-7-23, Springer
  • 169. YS Kwon, ST Kim, PS Song, DR Ryu, SY Choi, JY Lee A case of rabdomyolysis associated with simvastatin clopidogrel ‐combination therapy, Korean Journal Med 69:S906-S909, 2005복용 중인 환자에서 병합요법 후 Simvastatin Clopidogrel 발생한 횡문근 융해증 예
  • 170.NM Selby, CW McIntyre The acute cardiac effects of dialysis, Seminars in dialysis, vol 20 (3) pp 220-228, 2007
  • 171, A Covic, M Diaconita, P Gusbeth ,Haemodialysis increases QTc interval but not QTc dispersion in ESRD patients without manifest cardiac disease - Nephrology Dialysis Transplant vol 17(17) pp 2170-2177, 2002
  • 172. S Severi, E Grandi, C Pes, F Badiali, F Grandi et al - Calcium and potassium changes during haemodialysis alter ventricular repolarization duration: in vivo and in silico analysis, Nephrology Dialysis Transplant vol 2008,vol 23 (4) ,1378-1386, 2008
  • 173. VINC WU, LYU LIN, KDUN WU - QT interval dispersion in dialysis patients, Nephrology,vol10(2) pp109-113, 2005
  • 174. G Kantarcı, Ç Özener, S Tokay, A Bihorac, E Akoğlu - QT dispersion in hemodialysis and CAPD patients, Nephron,vol 91:739-741, 2002
  • 175. S Maule, M Veglio, F Mecca et al Autonomic neuropathy and QT interval in hemodialysed patients,Clinical Autonomic Research vol 14 (4) ; 233-239, 2004
  • 176. Z Averbukh, R Rosenberg, E Galperin et al, Cell-associated magnesium and QT dispersion in hemodialysis patients, Z Averbukh, American journal of Kidney disease vol 41(1) pp 196-202, 2003
  • 177. Z Averbukh, R Rosenberg, E Galperin et al, Cell-associated magnesium and QT dispersion in hemodialysis patients, Z Averbukh, American journal of Kidney disease vol 41(1) pp 196-202, 2003
  • 178. M Ileri, E Yetkin, I Tandoğan, I Hisar et al. Effect of habitual smoking on QT interval duration and dispersion,The American journal of kidney disease 2001 ;88(3):322-325 doi:10.1016/s0002-9149(01)01653-8- Excerpta Medica
  • 179. AJ Jaroszyński, WT Załuska, A Książek Effect of haemodialysis on regional and transmural inhomogeneities of the ventricular repolarisation phase, Nephron Clinical Practice, vol 99; pp 24-30 , 2005
  • 180. M Tuncer, G Süleymanlar, FF Ersoy et.al - Effects of hepatitis C virus infection on cyclosporine trough levels in renal transplant patients - Transplantation Proceedings vol 32(3):569-571,2000
  • 180. P Saravanan, NC Davidson - Risk assessment for sudden cardiac death in dialysis patients, Circulation: Arrhythmia and Electrophysiolgy vol 3 pp 553-559, 2010
  • 181. A Drighil, JE Madias, M Benjelloun et al Changes in the QT intervals, QT dispersion, and amplitude of T waves after hemodialysis, Annals of noninvasive electrocardiology vol12 (2) pp137-144,2007
  • 182. 维持性血液透析中的心律失常 [J] 童延清, 王颖, 朴志贤 - 国际移植与血液净化杂志, 2006 - 万方数据资源系统 首页 学术圈 知识脉络 投稿 专题 相似性检测 更多 ▼. 学术统计分析 专利分析(试用) 新方志电力行业 冶金行业 船舶行业 引用通知 移动阅读; 查新/跨库检索 科技文献分析 编审平台DOI注册 期刊统计分析与评价 OA论文托管 优先出版. 登录 | 注册 | 充值 | 帮助. ...
  • 183. D Ozdemir, T Mese, H Agin, S Calkavur, M Bak H.Impact of haemodialysis on QTc dispersion in children, Nephrology, vol10 (2) pp119-123, 2005
  • 184. M Koc, A Toprak, IC Ozener, A Bihorac, H.et al QT dispersion in renal transplant recipients, Nephron,vol 91pp250-254, 2002
  • 185. D Sit, AK Kadiroglu, H Kayabasi, ME Yilmaz, V Goral;Seroprevalence of hepatitis B and C viruses in patients with chronic kidney disease in the predialysis stage at a University hospital in Turkey; Intervirology,50(2):133-137, 2006
  • 186. C Ijoma, I Ulasi, B Anisiuba ANAEMIA PREDICTS PROLONGED QT INTERVAL IN PREDIALYSIS CHRONIC KIDNEY DISEASE PATIENTS, The Internet Journal of Cardiovascular Research,vol7(1) 2008
  • 186.MJ Pena, L Molina, L Hortal, R Gallego, JL Rodríguezet.al Estudio epidemiológico de la infección por el virus de la hepatitis C en una Unidad de Hemodiálisis; Enferm Infecc Microbiol Clin, 2000
  • 187. C Cardoso, G Salles - QT–interval parameters in end–stage renal disease, Clinical Autonomic Research, vol 14 (4) pp 214-221, 2004
  • 188. B Taner, U Abdulkadir, K Yener, et al - Magnesium changes during hemodialysis alter the QTc interval and QTc dispersion, Yener, Diálisis y Trasplante, vol 32 (4) pp 142-146,2011
  • 189. AMH Al-Saffar Pre and Post Haemodialysis: The Effect of Electrolyte Imbalance on ECGs of Patients with End Stage Renal Disease.Medical Journal of Babylon vol 8 (2) ,2011
  • 190.E Akarsu, HZ Tonbul, Y Selçuk, et.al Hemodiyaliz Hastalarında Hepatìt С Vırus Antıkoru Prevelansı: Kan Transfüzyonlarısayısı Ve Dìyalìz Süresínín Etkìlerì– Atatürk Üniversitesi Tıp Dergisi ;31:7-10 ,1999
  • 191. 长期吸烟对 QT 间期及 QT 离散度的影响黄志华, 范瑞云 - 中华现代内科学杂志, 2005 - journal.9med.net[摘要] 目的观察长期吸烟对QT 间期及QT 离散度的影响. 方法将140 例健康志愿者分为吸烟组及对照组, 每组各70 例, 常温下采集静息12 导联心电图, 其QT 间期及QT 离散度, 两组间比较用配对t 检验, P< 0.05, 有统计学意义. 结果吸烟组比对照组在肢体导联二(D2) 及
  • 192. Z Szabó A pitvari és kamrai artimogenitás vizsgálata testfelszíni elektrokardiográfiai módszerekkel hemodialízis során és diszlipidémiában, DEA- 2007 - ganymedes.lib.unideb.hu
  • 193. T Akpolat Hemodiyaliz ve Nozokomiyal‹ nfeksiyonlar; Hastane Infeksiyonlari. Dergisi vol 8:27-34, 2004
  • 194.M Başkol, T Akpolat, A Bedir et al Hemodiyaliz Ve SAPD Hastalarında Anti-HCV Sıklığı.-Journal of Experimental and Clinical Medicine, 2010
  • 195. G Fontanella, N Cámpora, C Gallo, MV Bernasconi Comportamiento del intervalo QT del Electrocardiograma durante la Enfermedad de Chagas en ratas de línea" l- fac.org.ar
  • 196. Alıcı T,Tekçe H,Değirmenci M et al Son Dönem Böbrek Yetmezliği Hastalarında Hemodiyaliz Sırasında Oluşan QT Dispersiyonu ve Bunu Etkileyen Faktörler Factors Affecting QT Dispersion, Türk Nefroloji Diyaliz ve Transplantasyon dergisi 14 (4) pp183-187,2005.
  • 197. E Akarsu, HZ Tonbul, Y Selcuk, H Kaya Transmission of Hepatitis C Virus Infectionto Spouses of Patients Undergoing Chronic Hemodialysis Nephron ,82 (4) :359-360, 1999
  • 198. P Saravanan, NC Davidson, JL Baez- Advances in Arrhythmia and Electrophysiology-Escuderovol 3(5), 2010 - American Heart Assocciation
  • 199. P Di Loreto, C Ronco, GVescovo -Long QT, alteration of calcium-phosphate product, prevalence of ventricular arrhythmias and sudden death in peritoneal dialysis patients: a Holter study- Italian Journal of Medicine,vol 8 (2) pp 99-104, 2012
  • 200. F Afshinnia, H Doshi, PS Rao ,The Effect of Different Dialysate Magnesium Concentrations on QTc Dispersion in Hemodialysis Patients - Renal Failure,vol 34 (4) pp 408-412, 2012
  • 201. Ciovicescu, Felix, et al. "Haemodialysis-induced electrolyte variation (serum calcium, magnesium and bicarbonate) and intradialytic heart rhythm disorders."Human & Veterinary Medicine 6.1 (2014)
  • 202.A Mete, O Saygılı, A Mete, et.al Effects of intravitreal bevacizumab (Avastin®) therapy on retrobulbar blood flow parameters in patients with neovascular age‐related macular degeneration- Journal of Clinical Ultrasound; 38 (2) : 66-70, 2010 doi:10.1002/jcu.20650
  • 203.A Mete, O Saygili, K Gungor,et.al. Does Ranibizumab (Lucentis®) Change Retrobulbar Blood Flow in Patients with Neovascular Age-Related Macular Degeneration?- Ophthalmic Research; 47:141-145, 2011
  • 204. T Ergun, H Lakadamyali - Doppler ultrasound evaluation of morphological and hemodynamical changes of hepatic and mesenteric structures in end-stage renal disease patients on regular hemodialysis- International urology and nephrology;42(1):205-210, 2010
  • 205. F Sattler, Validierung der retinalen statischen Gefäßanalyse bei chronisch hämodialysepflichtigen Patienten, 2012
  • 206.OE Okolo, AE Omoti. Ocular manifestations of chronic kidney disease among adult patients receiving hemodialysis, Expert Review of Ophthalmology;7(6):517-528, 2012
  • 207. HR Yazdi, S Faraji, F Ahmadi et al- Color Doppler indices of orbital arterial flow in end-stage renal disease patients; are the changes related to chronic hemodialysis or chronic renal failure?,Iranian Journal of Radiology; 9 (1):12-16, 2012
  • 208.SY Lin - Vibrational Spectral Biodiagnosis of Ocular Calcification, Applied Spectroscopy Reviews; 49 (1) :11- 63, 2013
  • 209.FKNFH Tow, QL Ooi, TY Wong, et.al Microvascular Dilatation after Haemodialysis Is Determined by the Volume of Fluid Removed and Fall in Mean Arterial Pressure, Kidney and Blood Pressure Research; 35(6): 644-648 , 2012
  • 210. T Akpolat, Z Malazgirt, Y Gök et.al Merkezimizdeki Sürekli Ayaktan Periton Diyalizi (SAPD) Uygulaması – Journal of Experimental and Clinical Medicine, 2010 - dergi.omu.edu.tr
  • 211. F Ulaş, Ü Doğan, A Keleş, et al - Evaluation of choroidal and retinal thickness measurements using optical coherence tomography in non-diabetic haemodialysis patients, International Ophthalmology; 33 (5) : 533-539, 2013
  • 211. M Yeksan, K Dallan Sürekli ayaktan peritoti diyalizi hastalarmda düçük anti-HCV prevalansi: nosokomiyal geçiçin önemi- Genel Tip Derg,12.2 (2002): 61-64. 2002
  • 212. ZI Yakut, R Karadag, A Akcay, et al- Effect of Dialysis Type on Orbital Vascular Flow in Patients with End-Stage Renal Disease, Renal failure;34(6):691-696, 2012
  • 213. Schurr P, Boeken U, Litmathe J, Feindt P, Kurt M, Gams E. Predictors of postoperative complications in octogenarians undergoing cardiac surgery. Thoracic and Cardiovascular Surgeon 2010; 58 (4): 200–203. (SCI)
  • 214. Osaka S. CABG for patients on hemodialysis: Comments at present. Annals of Thoracic and Cardiovascular Surgery 2010; 16 (2):69–71.(SCIE)
  • 215. Kucewicz-Czech E, Wojarski J, Zegleń S, Urbańska E, Przybylski R, Pawlak S, Maruszewski M, Czapla J, Zukowska-Szczechowska E, Zembala M. Cardiac surgery in dialysis-patients with end-stage renal failure | [Operacje kardiochirurgiczne u pacjentów dializowanych z powodu skrajnej niewydolności nerek] Kardiologia Polska 2010; 68 (9):1088–1090. (SCIE)
  • 216. Suehiro K, Okutani R. Perioperative complications in patients with end-stage renal disease undergoing pulmonary resection. J Anesthe Clinin Res 2011;2:3. DOI:10.4172/2155-6148.1000127
  • 217. M Tuncer, M Sarikaya, O Yegin, G Süleymanlar Relationship between hepatitis C virus infection and human leucocyte antigens in renal transplant patients Transplantation Proceedings vol31(8):3343-3345, 1999 .
  • 218. Coşkun İ, Çölkesen Y, Demirtürk OS, Tünel HA, Gülcan O, Türköz R. Perioperatif ultrafiltrasyonun açık kalp ameliyatı yapılan diyalize bağımlı hastalarda ameliyat sonrası sonuçları üzerine etkileri. The effects of perioperative ultrafiltration on postoperative outcomes in dialysis-dependent patients undergoing open heart surgery. Türk Göğüs Kalp Damar Cerrahisi Dergisi 2013;21(3):603-609. DOI: 10.5606/tgkdc.dergisi.2013.7133.
  • 219. 2Coşkun İ, Çölkesen Y, Demirtürk OS, Tünel HA, Gülcan O, Türköz R. Perioperatif ultrafiltrasyonun açık kalp ameliyatı yapılan diyalize bağımlı hastalarda ameliyat sonrası sonuçları üzerine etkileri. The effects of perioperative ultrafiltration on postoperative outcomes in dialysis-dependent patients undergoing open heart surgery. Türk Göğüs Kalp Damar Cerrahisi Dergisi 2013;21(3):603-609. DOI: 10.5606/tgkdc.dergisi.2013.7133.
  • 220. S Ahmad, L‐Carnitine in Dialysis Patients Seminars in dialysis, vol14(3) 209-217,2001
  • 221.Y Matsumoto, I Amano, S Hirose, et al Effects of L-carnitine supplementation on renal anemia responders to erythropoietin, Blood purification,vol 19 pp:24-32 2000
  • 222. TA Golper, S Goral, BN Becker, CB et al- L-carnitine treatment of anemia American journal of kidney diseases vol 41(4) pp 29-34, 2003
  • 223. CH Schröder The management of anemia in pediatric peritoneal dialysis patients, Pediatric Nephrology, vol(8) pp 805-809, 2003
  • 224.WH Horl, C Jacobs, IC Macdougall et.al European Best Practice Guidelines 14-16 Inadequate response to epoetin Nephrology DialysisTransplantation vol 15(4) pp 43-50, 2000 -
  • 225. GF Romagnoli, A Naso, G Carraro et al, Beneficial effects of L-carnitine in dialysis patients with impaired left ventricular function: an observational study Current Medical Research and Opinion vol 18(3) pp 172-175, 2002
  • 226. J Bommer Saving erythropoietin by administering L-carnitine? Nephrology Dialysis Transplantation, vol 14(12)pp2819-2821,1999
  • 227. AK Kadiroglu, ME Yilmaz, D Sit, IH Kara et al The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients, Renal Failure vol 27(4)pp367-372 , 2005
  • 228. H Argani, M Rahbaninoubar, A Ghorbanihagjo et al, Effect of L-carnitine on the serum lipoproteins and HDL-C subclasses in hemodialysis patients,Nephron Clinical Practice vol101(4)pp 174-179, 2005
  • 229. WH Hörl.Adjunctive therapy in anaemia management, Nephrology Dialysis Transplantation, vol 17(5)pp56-59, 2002
  • 230. SE Reuter, RJ Faull, AM Evans. L‐carnitine supplementation in the dialysis population : Are Australian patients missing out?(Review Article). Nephrology,vol 13(1)pp3-16,2008
  • 231.SE Reuter, RJ Faull, E Ranieri,et.al Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients,Nephrology Dialysis Transplantation vol 24 (3) pp 990-996, 2009
  • 232. MR Lilien, M Duran, JME Quak, et al Oral L-carnitine does not decrease erythropoietin requirement in pediatric dialysis, Pediatric Nephrology;vol 15pp17-20, 2000
  • 233.JS Berns, A Mosenkis Pharmacologic adjuvants to epoetin in the treatment of anemia in patients on hemodialysis - Hemodialysis International,vol 9(1)pp7-22, 2005
  • 234. 左旋卡尼汀的临床应用 施健, 刘苏, 谢渭芬 - 中国临床药学杂志, 2005 - 万方数据资源系统 摘要: 左旋卡尼汀(L-carnitine, LC), 又称左旋肉碱, 左旋肉毒碱, 是人体细胞内的一种基本成分, 为水溶性季铵类化合物, 相对分子质量162× 103, 是长链脂肪酸进入线粒体β 氧化必需的一种物质. 约75% LC 来自食物, 余25% 由人体自身合成, 合成部位主要有肝脏和 ...
  • 235. AH Mitwalli, JS Al-Wakeel, A Alam,et al L-carnitine supplementation in hemodialysis patients Saudi Journal of Kidney Diseases and Transplantation vol 16(1)pp17-22, 2005
  • 236. F Kara, M Yeksan. Hemodiyaliz Ünitemizde Son 10 Yılda Değişen Anti-Hepatit C Virüs (HCV) Prevalansı.– Türk Nefroloji Diyaliz ve Transplantasyon Dergisi vol 3:138-142, 2000
  • 237. İ Süleymanlar, T Sezer, M Sarıkaya, M Tuncer et al. Türk Diyaliz Hastalarında Hepatit C İnfeksiyonu Oluşumunda Doku Antijenlerinin RolüTürk Nefroloji Diyaliz ve Transplantasyon Dergisi 1:9-13 1998
  • 238. Y Coşkun, M Sayan, S Helvacı, K Dilek, R Mıstık- Anti-HCV Pozitif Hemodiyaliz Hastaları ve Renal Transplant Alıcılarında “Restriction Fragment Length Polymorphism (RFLP)” ileHCV Genotiplendirmesi – Viral hepatit Dergisi :10(1):28-33, 2005
  • 239. A Chattopadhyay, T Das Choudhury et al- Biochemical Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical- Biochemical Pharmacology;59(4):419-425, 2000
  • 240.LG Mantovani, A Belisari - L-carnitine use in hemodialyzed patients- American journal of kidney diseases, vol 34(2)pp 400 401,1999
  • 241. NV Olsen Central nervous system frontiers for the use of erythropoietin;Clinical infectious diseases, vol37(4):323-330, 2003
  • 242.M Bonomini, V Zammit, CD Pusey, et al.Pharmacological use of l-carnitine in uremic anemia: Has its full potential been exploited? Pharmacological Research vol 63(3)pp157-164, 2011
  • 243. F KURALAY, G ERSÖZ,U Akarca,Kronik Hepatitte Glutatyon S-Transferaz-Alfa'nınTanısal Yararlılığı- Turkiye Klinikleri Journal of Gastroenterohepatology, 2004;vol15(2):59-64 - turkiyeklinikleri.com.
  • 244.AG Fam Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient, Current rheumatology reports, vol 3 (1) :29-35,2001
  • 245.AL Kamper, AH Nielsen Uricosuric effect of losartan in patients with renal transplants Transplantation, 2001 ;vol 72(4) : 671-674
  • 246.A Azzadin, J Malyszko, JS Malyszko et al. Effects of combination of cyclosporine with losartan or enalapril on kidney function in uremic rats, Polish Journal of Pharmacology vol 54 pp469-473, 2002 ISSN 1230-6002
  • 247. M Mydlik, K Derzsiova, O Racz, et al- A modified dialyzer with vitamin E and antioxidant defense parameters; Kidney International;59:s144-s147 , 2001
  • 248.AL Kamper, AH Nielsen. Uricosuric effect of losartan in renal transplanted patients- Transplantation proceedings, 2001;33(1-2):1201
  • 249.A Covic, L Iancu, C Apetrei, et al Hepatitis virus infection in haemodialysis patients from Moldavia.Nephrology Dialysis Transplantation vol14(1):40-45 , 1999
  • 250. A DebskaSlizien, A Owczarzak, D Kunick et.al. Erythrocyte metabolism and renal anemia in hemodialyzed patients supplemented with L-Carnitine - Nephro-Urology vol 3(1) pp23-33, 2011
  • 251.Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients F Yakaryilmaz, O Alp Gurbuz, S Guliter,et.al. Renal Failure vol 28(8):729-735, 2006
  • 252.R Cibulka, J Racek, L Trefil, E Veselá et.al Deficit L-karnitinu u hemodialyzovaných nemocných a význam jeho suplementace,Klinicka Biochemie a Metabolizm vol13(34) pp29-31,2005
  • 253.I Dulau-Florea Infections with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: yellow spots on a blank map? Journal of Viral Hepatitis,vol 7(4):313-319, 2000
  • 254. M Wanic-Kossowska, M Kaźmierski et al Skojarzone leczenie niedokrwistości L-karnityną i erytropoetyną u chorych na przewlekłą niewydolność nerek poddanych hemodializoterapii, POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNE J VOL 117(1-2)PP14-19, 2007
  • 255. PR Benítez, FJG Campderá Tratamiento de la anemia en la insuficiencia renal crónica, Terapeutica-pp1-5, 2005 jano.es
ÜYELİKLER
  • European Dialysis And Transplant Nurses Association (EDTNA) Üyeliği.
  • European Dialysis And Transplant Association And European Renal Association (EDTA - ERA). Üyeliği.
  • International Society Of Nephrology (ISN) Üyeliği.
  • Türk Nefroloji Derneği Üyeliği.
  • Hipertansiyon Ve Böbrek Hastalıkları Derneği Üyeliği.
  • Türkiye Organ Nakli Merkezleri Koordinasyon Derneği Üyeliği ( Kurucu Üye).
  • International Society Of Organ Transplantation Üyeliği.
  • European Society Of Organ Transplantation Üyeliği.
  • American Society Of Nephrology Üyeliği.
  • New York Akademy Of Scıency Actıve Member.
HİZMET İÇİ EĞİTİM
  • 24-28 Ocak 1994 :”Continuous Renal Replacement Therapy” kursu , Lion ,Fransa.
  • 5-8 June 2000, Joint Meetıng Of Turkİsh Socıety Of Nephrology And Internatıonal Socıety Of Nephrology, Partıcıpated To “Basıc Renal Course And Forefront In Nephrology, İstanbul.
  • 5-9 Eylül 2001, Türk Nefroloji Derneği Ve ISPD(Internatıonal Socıety For Peritoneal Dialysis) İle Ortak Olarak Düzenlenen SAPD’de Güncel Yaklaşımlar Kursuna Katılmıştır, Kapadokya.
  • 13 September 2003 “1.st Turkİsh Socİety Of Nephrology Course On Hypertension,” Antalya.
  • Cannıng International Training And Development Advanced Presentation Skills, 22-23 June 2006, Stockholm.
  • Managing Risk and Improving Outcomes In Renal Transplantation EACCME Accredited Educational Activity, 15-16 march 2007, Seville, Spain.
  • 2014 World Transplant Congress pre-meeting courses, july 26-27, 2014, San Fransisco, CA, USA.
Son Güncelleme: 16.11.2017 13:51:15